UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2020

Commission File Number: 001-39169

 

 

Natura &Co Holding S.A.

(Exact name of registrant as specified in its charter)

 

 

Avenida Alexandre Colares, No. 1188, Sala A17-Bloco A

Parque Anhanguera

São Paulo, São Paulo 05106-000, Brazil

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F    ☒             Form 40-F    ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes    ☐            No    ☒

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes    ☐            No    ☒

 

 

 

 


NATURA &CO HOLDING S.A.

TABLE OF CONTENTS

 

ITEM   
1.    Quarterly Information (ITR) at June 30, 2020 and report on review of quarterly information (Free translation of version filed by Natura &Co Holding S.A. with the Brazilian Securities Commission).

 


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

NATURA &CO HOLDING S.A.
By:  

/s/ José Antonio de Almeida Filippo

Name:   José Antonio de Almeida Filippo
Title:   Principal Financial Officer
By:  

/s/ Itamar Gaino Filho

Name:   Itamar Gaino Filho
Title:   Chief Legal and Compliance Officer

Date: September 30, 2020

 


Item 1

Quarterly Information (ITR) at June 30, 2020 and report on review of quarterly information (Free translation of version filed by Natura &Co Holding S.A. with the Brazilian Securities Commission).

 


Natura &Co Holding S.A.

Quarterly Information (ITR)

at June 30, 2020 and report on

review of quarterly information

 

F-1


LOGO

(A free translation of the original in Portuguese)

Report on review of quarterly information

To the Board of Directors and Shareholders

Natura &Co Holding S.A.

Introduction

We have reviewed the accompanying parent company and consolidated interim accounting information of Natura &Co Holding S.A. (“Company”), included in the Quarterly Information Form (ITR) for the quarter ended June 30, 2020, comprising the balance sheet at that date and the statements of operations and comprehensive income for the quarter and six-month period then ended, and the statements of changes in equity and cash flows for the six-month period then ended, and a summary of significant accounting policies and other explanatory information.

Management is responsible for the preparation of the parent company and consolidated interim accounting information in accordance with the accounting standard CPC 21, Interim Financial Reporting, of the Brazilian Accounting Pronouncements Committee (CPC) and International Accounting Standard (IAS) 34, Interim Financial Reporting issued by the International Accounting Standards Board (IASB), as well as the presentation of this information in accordance with the standards issued by the Brazilian Securities Commission (CVM), applicable to the preparation of the Quarterly Information (ITR). Our responsibility is to express a conclusion on this interim accounting information based on our review.

Scope of review

We conducted our review in accordance with Brazilian and International Standards on Reviews of Interim Financial Information (NBC TR 2410—Review of Interim Financial Information Performed by the Independent Auditor of the Entity, and ISRE 2410—Review of Interim Financial Information Performed by the Independent Auditor of the Entity, respectively). A review of interim information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Brazilian and International Standards on Auditing and consequently did not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion on the interim information

Based on our review, nothing has come to our attention that causes us to believe that the accompanying parent company and consolidated interim accounting information included in the quarterly information referred to above has not been prepared, in all material respects, in accordance with CPC 21 and IAS 34 applicable to the preparation of the Quarterly Information, and presented in accordance with the standards issued by the CVM.

 

 

PricewaterhouseCoopers, Av. Francisco Matarazzo 1400, Torre Torino, São Paulo, SP, Brasil, 05001-903, Caixa Postal 60054,

T: +55 (11) 3674 2000, www.pwc.com.br

 

F-2


LOGO

Natura &Co Holding S.A.

Emphasis of Matter

Reissuance of Quarterly Information Form (ITR) and review report

On August 13, 2020, we issued an unqualified review report on the Quarterly Information (ITR) for the quarter ended June 30, 2020. We call your attention to Note 2.1(b) of the Quarterly Information (ITR), which describes that the ITR originally issued by the Company on August 13, 2020 is being reissued to include a reconciliation in Note 25.3, consequently, the predecessor auditor reissued its unqualified previously issued report dated August 14, 2019. Our conclusion is not qualified in relation to this matter.

Other matters

Statements of value added

The quarterly information referred to above includes the parent company and consolidated statements of value added for the six-month period ended June 30, 2020. These statements are the responsibility of the Company’s management and are presented as supplementary information under IAS 34. These statements have been subjected to review procedures performed together with the review of the quarterly information for the purpose of concluding whether they are reconciled with the interim accounting information and accounting records, as applicable, and if their form and content are in accordance with the criteria defined in the accounting standard CPC 09—Statement of Value Added. Based on our review, nothing has come to our attention that causes us to believe that these statements of value added have not been properly prepared, in all material respects, in accordance with the criteria established in this accounting standard, and consistent with the parent company and consolidated interim accounting information taken as a whole.

Audit and review of the corresponding amounts

prior year and period

The Quarterly Information (ITR) mentioned in the first paragraph includes accounting information corresponding to the statements of operations, comprehensive income for the quarter and six-month period ended June 30, 2019, to changes in shareholders’ equity, cash flows and value added for the six-month period ended June 30, 2019, presented for comparison purposes. The corresponding accounting information of the Company, for the periods of three and six months ended June 30,2019, was prepared by management based on the procedures described in Note 2.1(a).

The review of the Quarterly Information (ITR) for the quarter ended June 30, 2019 of Natura Cosméticos S.A. (currently, a wholly owned subsidiary of the holding Natura &Co Holding S.A.) was conducted under the responsibility of other independent auditors, who issued an unqualified review report dated September 30, 2020.

 

F-3


LOGO

Natura &Co Holding S.A.

The Quarterly Information (ITR) mentioned in the first paragraph also includes accounting information corresponding to the balance sheet as of December 31, 2019, obtained from the financial statements as of December 31, 2019, originally prepared before the reclassifications described in Note 25.3, which were performed in connection with the acquisition of Avon Products, Inc., and are presented for comparison purposes. The examination of the financial statements for the year ended December 31, 2019, as originally prepared, was conducted under the responsibility of other independent auditors, who issued unqualified audit opinion dated March 5, 2020.

As part of our review of the ITR for the quarter ended June 30, 2020, we reviewed the aforementioned reclassifications as they relate to assets and liabilities as of December 31, 2019, described in Note 25.3. Based on our review, nothing has come to our attention that such reclassifications are not appropriate or have not been correctly performed, in all material respects. We were not engaged to audit, review or apply any other procedures on the Company’s 2019 other financial information, and, therefore, we do not express an opinion or any form of assurance on the financial information for that year.

São Paulo, September 30, 2020

PricewaterhouseCoopers

Auditores Independentes

CRC 2SP000160/O-5

Leandro Mauro Ardito

Contador CRC 1SP188307/O-0

 

F-4


NATURA &CO HOLDING S.A.

BALANCE SHEET ON 30 JUNE 2020 AND 31 DECEMBER 2019

(All amounts in thousands of Brazilian reais - R$)

 

 

    Explanatory
note
  Controlling
Company
    Consolidated  
    06/2020     12/2019     06/2020     12/2019  

ASSETS

         

CURRENT

         

Cash and cash equivalents

  6     499,247       2,380,800       4,820,116       4,513,582  

Short-term investments

  7     1,583,045       669,769       2,570,204       1,025,845  

Trade receivables

  8     —         —         2,644,601       1,685,764  

Trade receivables - related parties

  31.1     506,876       —         —         —    

Inventories

  9     —         —         4,481,347       1,430,550  

Recoverable taxes

  10     —         5       1,045,201       395,640  

Income tax and social contribution

      2,196       —         328,974       113,478  

Derivative financial instruments

  5.2     —         —         179,302       —    

Other current assets

  14     —         —         799,222       265,198  
   

 

 

   

 

 

   

 

 

   

 

 

 
      2,591,364       3,050,574       16,868,967       9,430,057  
   

 

 

   

 

 

   

 

 

   

 

 

 

Assets non-current available for sale

  13     —         —         195,557       —    
   

 

 

   

 

 

   

 

 

   

 

 

 

Total current assets

      2,591,364       3,050,574       17,064,524       9,430,057  
   

 

 

   

 

 

   

 

 

   

 

 

 

NON-CURRENT

         

Recoverable taxes

  10     —         —         893,406       409,214  

Income tax and social contribution

      —         —         333,983       334,671  

Deferred income tax and social contribution

  11     71,868       —         975,892       374,448  

Judicial deposits

  12     —         —         600,340       337,255  

Derivative financial instruments

  5.2     —         —         2,019,871       737,378  

Short-term investments

  7     —         —         11,326       7,402  

Other non-current assets

  14     —         —         1,601,593       83,836  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total long-term assets

      71,868       —         6,436,411       2,284,204  
   

 

 

   

 

 

   

 

 

   

 

 

 

Investments

  15     21,686,515       3,392,677       —         —    

Property, plant and equipment

  16     —         —         5,350,765       1,773,889  

Intangible assets

  17     —         —         28,431,249       5,076,501  

Right of use

  18     —         —         3,809,973       2,619,861  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total non-current assets

      21,758,383       3,392,677       44,028,398       11,754,455  
   

 

 

   

 

 

   

 

 

   

 

 

 

 

    

         
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL ASSETS

      24,349,747       6,443,251       61,092,922       21,184,512  
   

 

 

   

 

 

   

 

 

   

 

 

 
    Explanatory
note
  Controlling
Company
    Consolidated  
    06/2020     12/2019     06/2020     12/2019  

LIABILITIES AND SHAREHOLDERS’ EQUITY

         

CURRENT

         

Borrowings, financing and debentures

  19     1,073,162       2,883,382       2,631,068       3,354,355  

Lease

  18.b     —         —         1,081,059       542,088  

Trade payables and reverse factoring

  20     13,799       —         5,709,969       1,829,756  

Trade payables - related parties

  31.1     330       —         —         —    

Payroll, profit sharing and social charges

      15,265       —         1,111,576       560,376  

Tax liabilities

  21     504       1,050       614,839       320,890  

Income tax and social contribution

      —         196,474       189,748       388,238  

Dividends and interest on shareholders’ equity payable

  28.b)     —         —         —         95,873  

Derivative financial instruments

  5.2     —         —         75,247       11,806  

Provision for tax, civil and labor risks

  22     —         —         127,825       18,650  

Other current liabilities

  23     —         —         1,322,558       396,391  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total current liabilities

      1,103,060       3,080,906       12,863,889       7,518,423  
   

 

 

   

 

 

   

 

 

   

 

 

 

NON-CURRENT

         

Borrowings, financing and debentures

  19     —         —         18,035,031       7,432,019  

Lease

  18.b     —         —         3,026,116       1,975,477  

Payroll, profit sharing and social charges

      1,082       —         20,904       —    

Tax liabilities

  21     —         —         108,808       122,569  

Deferred income tax and social contribution

  11     —         —         1,413,471       450,561  

Provision for tax, civil and labor risks

  22     —         —         1,185,943       201,416  

Other non-current liabilities

  23     —         —         1,165,297       121,702  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total non-current liabilities

      1,082       —         24,955,570       10,303,744  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL LIABILITIES

      1,104,142       3,080,906       37,819,459       17,822,167  
   

 

 

   

 

 

   

 

 

   

 

 

 

SHAREHOLDERS’ EQUITY

         

Capital stock

      6,917,037       1,485,436       6,917,037       1,485,436  

Treasury shares

  24.2     (13,955     —         (13,955     —    

Capital reserves

      10,945,096       1,210,924       10,945,096       1,210,924  

Legal profit reserve

  24.4     2,364       (149,020     2,364       (149,020

Retained losses

      (1,209,296     —         (1,209,296     —    

Equity appraisal adjustment

      6,604,359       815,005       6,604,359       815,005  
   

 

 

   

 

 

   

 

 

   

 

 

 

Shareholders’ equity attributed to the Company’s controlling shareholders

      23,245,605       3,362,345       23,245,605       3,362,345  
   

 

 

   

 

 

   

 

 

   

 

 

 

Non-controlling interest in shareholders’ equity of subsidiaries

      —         —         27,858       —    
   

 

 

   

 

 

   

 

 

   

 

 

 

Total shareholders’ equity

      23,245,605       3,362,345       23,273,463       3,362,345  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

      24,349,747       6,443,251       61,092,922       21,184,512  
   

 

 

   

 

 

   

 

 

   

 

 

 
 
*

The explanatory notes are an integral part of the interim financial statements.     

 

 

F-5


NATURA &CO HOLDING S.A.

STATEMENT OF INCOME

FOR THE THREE - AND SIX-MONTH PERIODS ENDED ON 30 JUNE 2020 AND 2019

(All amounts in thousands of Brazilian reais - R$, except for earnings per share in the period)

 

 

     Explanatory
note
   Controlling Company      Controlling Company      Consolidated     Consolidated  
     01/04/2020 to
30/06/2020
    01/04/2019 to
30/06/2019
     01/01/2020 to
30/06/2020
    01/01/2019 to
30/06/2019
     01/04/2020 to
30/06/2020
    01/04/2019 to
30/06/2019
    01/01/2020 to
30/06/2020
    01/01/2019 to
30/06/2019
 

CONTINUING OPERATIONS

                     

NET REVENUE

   26      —         —          —         —          6,987,180       3,403,709       14,505,174       6,318,859  

Cost of products sold

   27      —         —          —         —          (2,375,507     (964,555     (5,254,229     (1,773,727
     

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

GROSS PROFIT

        —         —          —         —          4,611,673       2,439,154       9,250,945       4,545,132  

OPERATING (EXPENSES) INCOME

                     

Selling, Marketing and Logistics expenses

   27      —         —          —         —          (3,171,808     (1,552,309     (6,448,997     (2,875,375

Administrative, R&D, IT and Project expenses

   27      (13,992     —          (23,970     —          (1,337,544     (567,221     (2,603,635     (1,104,252

Impairment loss on trade receivables

        —         —          —         —          (228,964     (42,609     (452,946     (118,037

Shareholders’ equity in subsidiaries

   15      (424,550     —          (1,136,652     —          —         —         —         —    

Other operating income (expenses), net

   30      (30,024     —          (177,848     —          74,676       8,087       (277,874     22,332  
     

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

OPERATING (LOSS) PROFIT BEFORE FINANCIAL RESULT

        (468,566     —          (1,338,470     —          (51,967     285,102       (532,507     469,800  
     

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Financial income

   29      14,802       —          65,884       —          665,538       414,057       2,225,722       792,159  

Financial expenses

   29      (6,603     —          (8,578     —          (934,079     (618,459     (2,721,858     (1,161,816
     

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

(LOSS) PROFIT BEFORE INCOME TAX AND SOCIAL CONTRIBUTION

        (460,367     —          (1,281,164     —          (320,508     80,700       (1,028,643     100,143  

Income tax and social contribution

   11      71,868       —          71,868       —          (44,853     (24,777     (139,656     (30,746
     

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

NET (LOSS) INCOME FOR THE PERIOD
CONTINUING

        (388,499     —          (1,209,296     —          (365,361     55,923       (1,168,299     69,397  
     

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

DISCONTINUED OPERATIONS

                     

NET LOSS OF DISCONTINUED OPERATIONS

   23      —         —          —         —          (26,722     —         (48,723     —    
     

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

NET LOSS FOR THE PERIOD

        (388,499     —          (1,209,296     —          (392,083     55,923       (1,217,022     69,397  
     

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

ATTRIBUTABLE TO

                     

The Company´s shareholders

        (388,499     —          (1,209,296     —          (388,499     55,923       (1,209,296     69,397  

Non-controlling shareholders

        —         —          —         —          (3,584     —         (7,726     —    
     

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 
        (388,499     —          (1,209,296     —          (392,083     55,923       (1,217,022     69,397  
     

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

(LOSS) EARNINGS PER SHARE IN THE PERIOD - R$

                     

Basic

        (0.3211     —          (1.0190     —          (0.3211     0.0649       (1.0190     0.0804  
     

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Diluted

        (0.3211     —          (1.0190     —          (0.3211     0.0645       (1.0190     0.0800  
     

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

 

*

The explanatory notes are an integral part of the interim financial statements.

 

F-6


NATURA &CO HOLDING S.A.

STATEMENT OF COMPREHENSIVE INCOME

FOR THE THREE- AND SIX-MONTH PERIODS ENDED ON 30 JUNE 2020 AND 2019

(All amounts in thousands of Brazilian reais - R$)

 

 

    Explanatory
note
  Controlling Company     Controlling Company     Consolidated     Consolidated  
    01/04/2020 to
30/06/2020
    01/04/2019 to
30/06/2019
    01/01/2020 to
30/06/2020
    01/01/2019 to
30/06/2019
    01/04/2020 to
30/06/2020
    01/04/2019 to
30/06/2019
    01/01/2020 to
30/06/2020
    01/01/2019 to
30/06/2019
 

NET (LOSS) INCOME FOR THE PERIOD

      (388,499     —         (1,209,296     —         (392,083     55,923       (1,217,022     69,397  

Other comprehensive income to be reclassified into income of the period in subsequent periods:

                 

Earnings in the conversion of interim financial statements of controlled companies abroad

  15     1,291,448       —         5,640,486       —         1,299,477       (208,714     5,648,515       (147,351

Exchange rate effect on the conversion from hyperinflationary economy

  15     104       —         (4,247     —         104       (584     (4,247     393  

Earnings from cash flow hedge operations

  5.2     —         —         —         —         (19,728     70,475       228,956       159,698  

Tax effects on earnings from cash flow hedge operations

      —         —         —         —         7,960       (22,773     (75,842     (53,701

Equity in earnings from cash flow hedge operation

      (19,728     —         228,956       —         —         —         —         —    

Equity in tax effects on earnings from cash flow hedge operations

      7,960       —         (75,842     —         —         —         —         —    
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive income for the period, net of tax effects

      891,285       —         4,580,057       —         895,730       (105,673     4,580,360       28,436  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

ATTRIBUTABLE TO

                 

The Company´s shareholders

      891,285       —         4,580,057       —         891,285       (105,673     4,580,057       28,436  

Noncontrolling shareholders

      —         —               —         4,445       —         303       —    
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
      891,285       —         4,580,057       —         895,730       (105,673     4,580,360       28,436  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

*

The explanatory notes are an integral part of the interim financial statements.

 

F-7


NATURA &CO HOLDING S.A.

STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY

FOR THE SIX-MONTH PERIODS ENDED ON 30 JUNE 2020 AND 2019

(All amounts in thousands of Brazilian reais - R$)

 

 

                      Capital reserves                             Equity
appraisal
adjustment
                   
                      Surplus on           Additional    

Income
from

transaction

with non-

    Legal profit reserve     Retained     Other    

Shareholders’

equity attributed

          Total  
    Explanatory
note
    Capital
stock
    Treasury
shares
    issue/sale of
shares
    Special
reserve
    paid-in
capital
    controlling
shareholders
    Legal     Tax
incentives
    Retained
earnings
    (losses)
earnings
    comprehensive
income
    to controlling
shareholders
    Non-Controlling
Shareholders
    shareholders’
equity
 

BALANCES ON 31 DECEMBER 2018 - Natura Cosméticos S.A. (Note 2.1(a))

      427,073       (19,408     72,216             257,114       (92,066     18,650       82,072       1,336,293             492,158       2,574,102             2,574,102  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income for the period

      —         —         —         —         —         —         —         —         —         69,397       —         69,397       —         69,397  

Exchange rate effect on the conversion from hyperinflationary economy

      —         —         —         —         —         —         —         —         —         —         393       393       —         393  

Other comprehensive income

      —         —         —         —         —         —         —         —         —         —         (41,354     (41,354     —         (41,354
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total comprehensive income for the period

      —         —         —         —         —         —         —         —         —         69,397       (40,961     28,436       —         28,436  

Capital increase

      24,242       —         —         —         —         —             —         —         —         24,242       —         24,242  

Transactions in stock and restricted shares option plans:

                             

Provision for stock and restricted shares option plans

      —         —         —         —         40,285       —         —         —         —         —         —         40,285       —         40,285  

Exercise of stock and restricted shares option plans

      —         12,717       2,998       —         (17,857     —         —         —         —         —         —         (2,142     —         (2,142

Effect of Hyperinflationary economy adjustment

      —         —         —         —         34,145       —         —         —         71       —         —         34,216       —         34,216  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

BALANCES ON 30 JUNE 2019 - Natura Cosméticos S.A. (Note 2.1(a))

      451,315       (6,691     75,214       —         313,687       (92,066     18,650       82,072       1,336,364       69,397       451,197       2,699,139       —         2,699,139  

BALANCES ON 31 DECEMBER 2019

      1,485,436      

 
    1,096,398       206,592       —         (92,066     —         —         (149,020     —         815,006       3,362,346       —         3,362,346  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss for the period

      —         —         —         —         —         —         —         —         —         (1,209,296     —         (1,209,296     (7,726     (1,217,022

Exchange rate effect on the conversion from hyperinflationary economy

      —         —         —         —         —         —         —         —         —         —         (4,247     (4,247     —         (4,247

Other comprehensive income

      —         —         —         —         —         —         —         —         —         —         5,793,600       5,793,600       8,029       5,801,629  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total comprehensive income for the period

      —         —         —         —         —         —         —         —         —         (1,209,296     5,789,353       4,580,057       303       4,580,360  

EGM 30 April 2020

    24.3       —         —         —         (147,592     —         —             147,592       —         —         —         —         —    

Subscription of shares through the Board of Directors’ Meeting held on 3 January 2020

    24.1       3,397,746       —         9,877,148       —         —         —             —         —         —         13,274,894       27,555       13,302,449  

Subscription of shares through the Board of Directors’ Meeting held on 30 June 2020

    24.1       1,995,107       —         —         —         —         —             —         —         —         1,995,107       —         1,995,107  

Share repurchase

      —         (54,936     —         —         —         —             —         —         —         (54,936     —         (54,936
Transactions in stock and
restricted shares option
plans:
                                                                          —       —       —    

Provision for stock and restricted shares option plans

      —         —         —         —         33,944       —         —         —         —         —         —         33,944       —         33,944  

Exercise of stock and restricted shares option plans

      38,748       40,981       —         —         (56,007     —         —         —         —         —         —         23,722       —         23,722  

Effect of Hyperinflationary economy adjustment

      —         —         —         —         26,679       —         —         —         3,792       —         —         30,471       —         30,471  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

BALANCES ON 31 JUNE 2020

      6,917,037       (13,955     10,973,546       59,000       4,616       (92,066     —         —         2,364       (1,209,296     6,604,359       23,245,605       27,858       23,273,463  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

*

The explanatory notes are an integral part of the interim financial statements.

 

F-8


NATURA &CO HOLDING S.A.

STATEMENT OF CASH FLOWS

FOR THE THREE-MONTH PERIODS ENDED ON 30 JUNE 2020 AND 2019

(All amounts in thousands of Brazilian reais - R$)

 

 

     Explanatory
note
   Controlling Company      Consolidated  
          06/2020     06/2019      06/2020     06/2019  

CASH FLOW FROM OPERATING ACTIVITIES

            

Net (loss) income for the period

        (1,209,296     —          (1,217,022     69,397  

Adjustments to reconciliate net income for the period with net cash generated by operating activities:

            

Depreciation and amortization

   16, 17 e 18      —         —          1,329,717       536,700  

Interest on short-term investments

        (12,350     —          (50,546     (37,445

Provision (reversal of provision) from swap and forward derivative contracts

        —         —          (1,254,269     116,485  

Provision (reversal of provision) for tax, civil and labor risks

        —         —          97,703       10,450  

Inflation adjustment of judicial deposits

        —         —          (6,216     (7,447

Inflation adjustment of contingencies

   22      —         —          8,629       5,125  

Income tax and social contribution

   11      (71,868     —          139,656       30,746  

Income from sale and write-off of property, plant and equipment and intangible assets

   16 e 17      —         —          8,342       12,970  

Equity in subsidiaries

   15      1,136,652       —          —         —    

Interest and exchange rate variation on leases

   18.b      —         —          121,425       64,137  

Interest and exchange rate variation on borrowings and financing

   19      38,363       —          1,658,428       166,350  

Restatement and exchange rate variation on other assets and liabilities

        (130,263     —          690,246       1,505  

Provision (reversal of provision) for losses from property, plant and equipment and intangible assets

   16 e 17      —         —          16,144       (11,084

Provision (reversal of provision) for stock option plans

        (16,796     —          (24,930     26,903  

Actual losses and provision for losses with trade receivables, net of reversals

   8      —         —          397,409       118,037  

Provision (reversal of provision) for inventory losses, net

   9      —         —          190,763       72,980  

Provision (reversal of provision) for post-employment health care plan

   28.1      —         —          (6,008     3,971  

Effect from hyperinflationary economy

        —         —          26,468       29,423  

Other provision (reversals)

        —         —          (114,286     (129,469
     

 

 

   

 

 

    

 

 

   

 

 

 
        (265,558     —          2,011,653       1,079,734  
     

 

 

   

 

 

    

 

 

   

 

 

 

VARIANCES IN:

            

Trade receivables

        (5,802     —          217,048       22,826  

Inventories

        —         —          (445,220     (352,862

Recoverable taxes

        —         —          (205,187     5,993  

Other assets

        —         —          466,271       (71,429

Domestic and foreign trade payables

        14,110       —          (2,126,571     (64,499

Payroll, profit sharing and social charges, net

        16,347       —          385,026       (24,366

Tax liabilities

        (546     —          (75,973     (74,947

Other liabilities

        (60     —          (594,700     139,536  
     

 

 

   

 

 

    

 

 

   

 

 

 

CASH (USED IN) GENERATED BY OPERATING ACTIVITIES

        (241,509     —          (367,653     659,986  
     

 

 

   

 

 

    

 

 

   

 

 

 

OTHER CASH FLOWS FROM OPERATING ACTIVITIES

            

Recovery (payment) of income tax and social contribution

        (198,664     —          (411,768     (224,691

Release (payments) of judicial deposits

        —         —          27,016       3,564  

Payments related to tax, civil and labor lawsuits

   22      —         —          (84,585     (12,911

Payments due to settlement of derivative transactions

        —         —          4,040       (33,308

Payment of interest on lease

   18.b      —         —          (133,695     (64,137

Payment of interest on borrowings, financing and debentures

   19      (21,678     —          (531,679     (257,284
     

 

 

   

 

 

    

 

 

   

 

 

 

CASH (USED IN) GENERATED BY OPERATING ACTIVITIES

        (461,851     —          (1,498,324     71,219  
     

 

 

   

 

 

    

 

 

   

 

 

 

CASH FLOW FROM INVESTING ACTIVITIES

            

Cash from acquisition of subsidiary

   4      —         —          2,636,108       —    

Additions of property, plant and equipment and intangible assets

   16 e 17      —         —          (308,576     (217,440

Proceeds from sale of property, plant and equipment and intangible assets

        —         —          53,982       8,454  

Short-term investments

        (1,957,878     —          (5,972,283     (3,547,736

Redemption of short-term investments

        1,048,283       —          4,548,629       4,038,578  

Redemption of interest on short-term investments

        8,670       —          29,886       38,717  

Investment in subsidiaries

   15      (300,000     —          —         —    
     

 

 

   

 

 

    

 

 

   

 

 

 

CASH (USED IN) GENERATED BY INVESTING ACTIVITIES

        (1,200,925     —          987,746       320,573  
     

 

 

   

 

 

    

 

 

   

 

 

 

CASH FLOW FROM FINANCING ACTIVITIES

            

Amortization of lease - principal

   18      —         —          (380,902     (284,803

Amortization of borrowings, financing and debentures – principal

   19      (2,326,905     —          (2,485,231     (594,912

New borrowings, financing, lease and debentures

   18 e 19      500,000       —          1,341,538       294,842  

Acquisition of treasury shares, after receipt of option strike price

        (54,936     —          (13,955     (2,142

Payment of dividends and interest on equity for the previous year

   31.2      —         —          (133,937     (152,979

Receipt of funds due to settlement of derivative transactions

        —         —          82,194       1,874  

Acquired company’s liability incurred by acquiror

        (370,791     —          (370,791     —    

Capital payment

        —         —          —         24,242  

Capital increase

        2,033,855       —          2,033,855       —    
     

 

 

   

 

 

    

 

 

   

 

 

 

CASH (USED IN) GENERATED BY FINANCING ACTIVITIES

        (218,777     —          72,771       (713,878
     

 

 

   

 

 

    

 

 

   

 

 

 

Effect of exchange rate variation on cash and cash equivalents

        —         —          744,340       (10,287
     

 

 

   

 

 

    

 

 

   

 

 

 

DECREASE IN CASH AND CASH EQUIVALENTS

        (1,881,553     —          306,534       (332,373
     

 

 

   

 

 

    

 

 

   

 

 

 

Opening balance of cash and cash equivalents

   6      2,380,800       —          4,513,582       1,215,048  

Closing balance of cash and cash equivalents

   6      499,247       —          4,820,116       882,675  
     

 

 

   

 

 

    

 

 

   

 

 

 

DECREASE IN CASH AND CASH EQUIVALENTS

        (1,881,553     —          306,534       (332,373
     

 

 

   

 

 

    

 

 

   

 

 

 

 

*

The explanatory notes are an integral part of the interim financial statements.

 

F-9


STATEMENT OF VALUE ADDED

FOR THE THREE-MONTH PERIODS ENDED ON 30 JUNE 2019 AND 2018

(All amounts in thousands of Brazilian reais - R$)

 

 

     Explanatory
note
   Controlling Company      Consolidated        
     06/2020           06/2019      06/2020           06/2019        

INCOME

        (177,848       —          15,937,371         7,930,410    
     

 

 

     

 

 

    

 

 

     

 

 

   

Sale of goods, products and services

        —           —          16,414,006         8,019,386    

Provision for doubtful accounts, net of reversals

   8      —           —          (86,717       20,550    

Other operating expenses, net

        (177,848       —          (389,918       (109,526  

INPUTS ACQUIRED FROM THIRD PARTIES

        (5,755       —          (11,064,226       (4,614,161  
     

 

 

     

 

 

    

 

 

     

 

 

   

Cost of products sold and services provided

        —           —          (5,674,891       (2,608,360  

Materials, electricity, outsourced services and others

        (5,755       —          (5,389,335       (2,005,801  

GROSS VALUE ADDED

        (183,603       —          4,873,145         3,316,249    

RETENTIONS

        —           —          (1,329,718       (536,700  
     

 

 

     

 

 

    

 

 

     

 

 

   

Depreciation and amortization

   16 and 17      —           —          (1,329,718       (536,700  

VALUE ADDED PRODUCED BY THE COMPANY

        (183,603       —          3,543,427         2,779,549    

TRANSFERRED VALUE ADDED

        (1,070,768       —          2,225,722         792,159    
     

 

 

        

 

 

     

 

 

   

Equity in subsidiaries

   15      (1,136,652       —          —           —      

Financial income - including inflation adjustments and exchange rate variations

   29      65,884         —          2,225,722         792,159    

TOTAL VALUE ADDED TO DISTRIBUTE

        (1,254,371       —          5,769,149         3,571,708    
     

 

 

     

 

 

    

 

 

     

 

 

   

DISTRIBUTION OF VALUE ADDED

        (1,254,371     100     —          5,769,149       100     3,571,708       100
     

 

 

     

 

 

    

 

 

     

 

 

   

Payroll and social charges

   28      18,215       -1     —          3,065,697       53     1,452,056       41

Taxes, fees and contributions

        (71,868     6     —          1,184,713       21     875,746       25

Financial expenses and rentals

        8,578       -1     —          2,735,761       47     1,174,509       33

Retained losses

        (1,209,296     96     —          (1,209,296     -21     69,397       2

Minority holders’ share in the retained profit

        —         —         —          (7,726     0     —         —    

 

*

The explanatory notes are an integral part of the interim financial statements.

 

F-10


LOGO

 

INDEX OF EXPLANATORY NOTES

 

1. GENERAL INFORMATION

  

2. SUMMARY OF THE MAIN ACCOUNTING PRACTICES

  

3. CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS

  

4. BUSINESS COMBINATION

  

5. FINANCIAL RISK MANAGEMENT

  

6. CASH AND CASH EQUIVALENTS

  

7. SHORT-TERM INVESTMENTS

  

8. TRADE RECEIVABLES

  

9. INVENTORIES

  

10. RECOVERABLE TAXES

  

11. INCOME TAX AND SOCIAL CONTRIBUTION

  

12. JUDICIAL DEPOSITS

  

13. ASSETS AVAILABLE FOR SALE

  

14. OTHER CURRENT AND NON-CURRENT ASSETS

  

15. INVESTMENTS

  

16. PROPERTY, PLANT AND EQUIPMENT

  

17. INTANGIBLE ASSETS

  

18. RIGHT OF USE AND LEASE

  

19. BORROWINGS, FINANCING AND DEBENTURES

  

20. TRADE PAYABLES AND REVERSE FACTORING OPERATIONS

  

21. TAX OBLIGATIONS

  

22. PROVISION FOR TAX, CIVIL AND LABOR RISKS

  

23. OTHER LIABILITIES

  

24. SHAREHOLDERS’ EQUITY

  

25. BUSINESS SEGMENT INFORMATION

  

26. NET INCOME

  

27. OPERATING EXPENSES AND COST OF PRODUCTS SOLD

  

28. EMPLOYEE BENEFITS

  

29. FINANCIAL INCOME (EXPENSES)

  

30. OTHER OPERATING INCOME (EXPENSES), NET

  

31. TRANSACTIONS WITH RELATED PARTIES

  

32. COMMITMENTS

  

33. INSURANCE COVERAGE

  

34. ADDITIONAL INFORMATION TO THE CASH FLOW STATEMENTS

  

35. SUBSEQUENT EVENTS

  

36. APPROVAL FOR ISSUE OF THE INTERIM ACCOUNTING INFORMATION

  

 

F-11


LOGO

 

1.

GENERAL INFORMATION

NATURA &CO HOLDING S.A. (“Natura &Co” or the “Company”) formerly referred to as Natura Holding S.A., was incorporated on 21 January 2019 with the purpose of holding interest in other companies, as a partner or shareholder, in Brazil or abroad (“holding company”). The purpose of the Company is to manage shareholding interest in companies that operate mainly in the cosmetics industry, fragrances and personal hygiene sector, through the development of manufacturing, distribution and commercialization of its products. The group’s main brand is “Natura”, followed by the brands “Avon”, “The Body Shop” and “Aesop”. In addition to using the retail market, e-commerce, business to business (“ B2B”) and franchises as sales channels for the products, the subsidiaries stand out for the work of the direct sales channel carried out mainly by Natura, The Body Shop and Avon Consultant(s).

The Company is a publicly-traded corporation, domiciled in São Paulo, registered in the special trading segment called “Novo Mercado” in the B3 S.A. – Brasil, Bolsa, Balcão (B3), under ticker “NTCO3.”

After several restructuring activities which took place for the process of acquiring Avon Products, Inc. (“Avon”), completed on 3 January 2020 (Note 4), the Company became the holding company for the Natura group. Additionally, in December 2019 it became the holder of 100% of shares of Natura Cosméticos S.A. (“Natura”), under ticker NATU3. Thus, since 18 December 2019, NATU3 shares have no longer been traded in B3 S.A. – Brasil, Bolsa, Balcão, and trading with NTCO3 shares has started in the “Novo Mercado” segment of B3. On 6 January 2020, the Company started to trade American Depositary Receipts on the New York Stock Exchange (“NYSE”), under the ticker “NTCO”.

 

2.

SUMMARY OF THE MAIN ACCOUNTING PRACTICES

 

2.1

Declaration of compliance and preparation basis

The Company’s condensed interim accounting information, included in the Quarterly Information Form - ITR pertaining to the quarter ended 30 June 2020, encompasses the individual and consolidated interim accounting information prepared pursuant to Technical Pronouncement “CPC 21 - Interim Statements”, approved by the Brazilian Securities Commission (“CVM”) and the “International Accounting Standard (“IAS”) 34 - Interim Financial Reporting”, issued by the International Accounting Standards Board (IASB).

The Management confirms that all relevant information in the interim accounting statements, and only this information, is being disclosed, and it corresponds to the information used in the development of its business management activities. The interim accounting information was prepared based on the historical costs, except for certain financial instruments measured by their fair value, as described in the accounting practices.

The main accounting practices applied upon preparing this individual and consolidated interim accounting information are disclosed in explanatory note No. 2 of the Company’s financial statements, pertaining to the fiscal year ended 31 December 2019, issued on 5 March 2020, except (i) for the presentation of information on segments (Note 25), which was changed as a result of the acquisition of Avon (Note 4). The same policies apply for comparison of the six-month period ended 30 June 2019, and (ii) practical expedient application to rent concessions in lease contracts which occurred as a direct consequence of the Covid-19 pandemic.

The information on explanatory notes did not go through significant changes in comparison to 31 December 2019, which is why it is not fully presented in this interim accounting information and must, therefore, be read jointly with the last annual financial statement.

 

  a)

Presentation basis for the Company’s consolidated accounting statements before the corporate restructuring presented in the Company’s annual financial statement in Note 1

As presented in the Company’s annual financial statements for the fiscal year ended 31 December 2019, the Company’s consolidated accounting information presented in this financial statement that is prior to the corporate restructuring for the acquisition of Avon was prepared pursuant to the accounting practices of the preceding costs. Thus, the comparative and consolidated historic information presented herein for the statements of income, comprehensive income statement, statement of changes in net equity, cash flow statement and added value statement for the comparative period ended on 30 June 2019, refer to the consolidated information of the entire subsidiary Natura Cosméticos S.A., and were obtained from the Quarterly Information - ITR pertaining to the second quarter of 2019, except for earnings per share and share-based payments that were restated as a result of the share bonus shown in note 24.1.

 

F-12


LOGO

 

  b)

Restatement of the interim financial statement – 30 June 2020

On 13 August 2020, the Company issued the Quarterly Information of 30 June 2020. On this date, the Company’s Management is reissuing the interim information originally issued due to the inclusion of segment reconciliation in Note 25.3, with the consequent reissue, by predecessor auditor, of his previously issued report.

 

2.2

Hyperinflationary economy

Information pertaining to the hyperinflationary economy was presented in the Company’s 2019 annual financial statements, in Note 3.2.1.a.

In the six-month period ended 30 June 2020, the application of CPC 42 / IAS 29 resulted in: (i) a negative impact on the financial results of Brazilian Real (“R$”) 5,556 (30 June 2019 R$ 5,864); and (ii) a negative impact on the net profit for the fiscal year of R$ 22,221 (30 June 2019 R$ 29,888), which includes the effect of the conversion of the income statement by the exchange rate on the year’s end date, instead of the average monthly exchange rate, positive impact in the sum of R$ 4,247 (30 June 2019 negative impact of R$ 393). The capital reserve and profit reserve also increased R$ 256,679 and R$ 151,384, respectively.

 

2.3

Consolidation

 

  a)

Investments in subsidiaries

Information pertaining to the consolidation was presented in the Company’s 2019 annual financial statements, in Note 3.3. a), except for the movement in the table below:

 

     Interest - %  
     06/2020      12/2019  

Direct interest:

     

Avon Products, Inc

     100.00        —    

Natura Cosméticos S.A.

     100.00        100.00  

Natura &Co International S.à r.l.

     100.00        —    

The activities of the direct subsidiaries are as follows:

 

   

Natura Cosméticos S.A.: is a publicly held corporation organized in accordance with the laws of the Federative Republic of Brazil on 6 June 1993, with an indefinite term. Created in 1969 in São Paulo, Brazil, it is among the top ten direct sales companies in the world. Under the Natura brand, most of the products have a natural origin, developed with ingredients from the Brazilian biodiversity and mainly distributed by means of direct sales by independent beauty consultants. It also sells through e-commerce and an expanded own store chain, composed of 43 stores in Brazil and nine stores abroad (in the USA, France, Argentina and Chile), 256 franchise stores, as well as presence in approximately 3,500 drugstores on 30 June 2019.

 

   

Avon Products, Inc.: Global manufacturer and trader of beauty products and other consumer products, with operations starting in 1886, and constituted pursuant to the laws of the State of New York on 27 January 1916. Its businesses are conducted in the beauty industry and other consumer goods. A direct sales company for the creation, manufacture and trade of beauty and other unrelated products. Its business is held mainly via the direct sales channel.

 

   

Natura &Co International S.à.r.l.: a company organized in 2020 with the purpose of acquiring, managing and selling interests in national and foreign companies, other than raising and borrowing funds for other consolidated entities of the Company.

 

2.4

Presentation of information per segment

Information per operating segment presented in note 25 is consistent with the internal report provided to the chief operating decision maker.

The main decision-making body of the Company, which is responsible for defining the allocation of resources and for the performance assessment of the operating segments, is Natura &Co Holding S.A.’s Board of Directors, which is assisted by the Group’s Operational Committee (“GOC”).

The GOC, which includes the Chief Executive Officers (“CEOs”) of Natura &CO, Natura, Avon, The Body Shop and Aesop, in addition to representatives of key business areas (Finance, Human Resources, Business Strategy and Development, Legal, Innovation and Sustainability, Operations and Corporate Governance), is responsible for, among other things, monitoring the implementation of short and long-term strategies and making recommendations to the Board of Directors regarding the management of the Group, from the perspective of results, allocation of resources among business units, cash flow and talent management.

 

F-13


LOGO

 

3.

CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS

The preparation of the individual and consolidated interim accounting information requires the Management to employ certain assumptions and accounting estimates based on experience and other factors considered relevant, which affect the value of assets and liabilities and may present results that differ from actual results. The effects resulting from accounting estimate reviews are recognized in the review period.

The significant judgments made by the Company are related to the recognition of revenue and lease.

The areas requiring a greater level of judgment and which are more complex, as well as the areas in which the premises and estimates are significant for the financial statements, are disclosed below.

There were no significant changes in the estimates and premises employed upon preparing the interim accounting information for the quarter ended 30 June 2020, or in the calculation methods used, in relation to the ones presented in explanatory note No. 3 of the Company’s financial statements pertaining to the fiscal year ended 31 December 2019, issued on 5 March 2020, except for the fair value estimates of the business combination (note 4), analyses of the potential impacts of Covid-19 (note 5.3) and impairment evaluations (note 17.a).

 

F-14


LOGO

 

4.

BUSINESS COMBINATION

Acquisition of Avon Products Inc. (“Transaction”)

On 3 January 2020, after fulfilling all conditions precedent, as disclosed in the Company’s 2019 annual financial statements, issued on 5 March 2020, explanatory note 1(a) and as a subsequent event to note 35, the Transaction was completed, and the effects of the merger of Nectarine Merger Sub II into Avon, with the latter being the surviving entity, came into force. Subsequently, Nectarine Merger Sub I was merged into Natura &Co, with the latter being the surviving entity. As a result of the mergers, on 3 January 2020, Avon became a full subsidiary of the Company, and Avon’s former shareholders became shareholders of the Company.

As a result, Natura &Co acquired control of Avon and the acquisition was accounted for under the acquisition method.

Transaction costs incurred by the Controlling Company until the completion of the transaction on 3 January 2020 amount to approximately R$ 112 million.

The following table summarizes the preliminary calculation of the fair value of the compensation transferred on 3 January 2020.

 

     In millions of R$, except
for the number of shares
 

Number of Avon outstanding common shares as of 3 January 2020

     536,383,776  

Multiplied by the exchange ratio of 0.600 Natura &Co Holding Shares per each Avon common share

     321,830,266  

Multiplied by the market price of Natura &Co shares on 3 January 2020

     41,00  
  

 

 

 

Compensation in the issuance of shares

     13,195  

Adjustment to the transferred compensation (a)

     171  
  

 

 

 

Fair value of the compensation to be transferred

     13,366  
  

 

 

 

 

(a)

Related to the effects of potential replacements and settlements of share-based payment plans, of which the amount of R$ 80 thousand refers to the share-based payment plans of Avon, in which it was substituted by Natura &Co, and R$ 91 thousand refers to the stock option plans liquidated as a result of the conclusion of the transaction. These are pre-combination installments that were regarded as transferred compensation.

Natura &Co has yet to conclude the process of allocation of the transferred compensation among the identified assets and liabilities acquired for their fair value. The table below shows the preliminary allocation prepared by the Company and the goodwill resulting from the non-allocated part. Differences between the preliminary estimates and the final recognition of the acquisition may occur and they may be relevant. Accounting standard “CPC 15/ IFRS 3 - Business combination” allows the Company to finalize this process of allocation of the transferred compensation among identified assets and liabilities within up to 12 months counted from the acquisition date. Natura &Co is analyzing the allocation of the transferred compensation to the identified assets and liabilities acquired for their fair value.

 

F-15


LOGO

 

     In millions of R$  

Total estimated compensation to be transferred:

     13,366  

(-) Fair value of acquired assets:

  

Cash and cash equivalent

     2,636  

Accounts receivable(1)

     1,135  

Inventories

     1,942  

Other current assets and restricted cash

     1,056  

Assets available for sale

     187  

Property, plant and equipment

     2,886  

Income tax and deferred social contribution

     667  

Assets of right of use

     565  

Other non-current assets

     475  

Judicial deposits

     284  

Recoverable taxes

     518  

Employee benefit plan

     553  

Intangible assets (2)

     5,710  

(+) Fair value of liabilities assumed:

  

Current liabilities

     6,267  

Provision for contingencies (3)

     724  

Long-term debt

     7,078  

Long-term lease

     588  

Deferred income tax (5)

     728  

Other liabilities

     809  
  

 

 

 

(-) Net assets

     2,420  

Interest of non-controlling shareholders

     28  
  

 

 

 

Goodwill (4)

     10,974  
  

 

 

 

 

(1)

On the acquisition date, the fair value of the accounts receivable is equal to their accounting value, net of provision for expected losses in the amount of R$ 270.2 million.

(2)

The fair value of intangible assets includes intangible assets acquired and registered by Avon prior to the fair value allocation in the sum of R$ 291, added to the effects of allocation of the fair value of the following items:

 

    

Nature

   Estimated fair
value (in
millions of
Reais)
     Estimated
useful life
 

Trade name “Avon”

   Represents the fair value of trade name “Avon”      1,893        Indefinite  

Main brands

   Represents the fair value of “Main brands”      518        20 years  

Developed technologies

   Represents the fair value of all technology required to develop Avon products, including product formulas, labeling data, manufacturing processes, regulatory approvals, packages of products and designs.      1,132        7 years  

Sales representatives

   Represents the fair value of Avon’s relationship with its sales representatives.      1,876        14 years  
     

 

 

    

Total

        5,419     
     

 

 

    

 

(3)

The provision for contingent risks demonstrated in the chart above by the sum corresponds to the historic value recorded by Avon, given that the Company is still assessing the fair value estimates, and also identifying additional contingencies which fit the recognition requirement established in paragraph 23 of CPC 15 (IFRS 3). That is, contingencies that: (i) represent a present obligation arising from past events, and (ii) can be reliably measured, regardless of the loss probability.

(4)

Goodwill pertaining to the strong market position and geographic regions that will result in a more diversified and balanced global portfolio, as well as future expected profitability and operational synergies, such as supply, manufacturing, distribution and efficiency of the administrative structure and revenue growth. This goodwill arising from the transaction is not expected to result in a tax benefit or to be deductible for tax purposes.

(5)

Consists of net operating loss deferred tax assets of approximately R$311 million and other net deferred tax liabilities of R$1,039 million.

 

F-16


LOGO

 

Since the acquisition date, Avon has contributed R$ 7,510.7 million of net revenues and R$ 1,041 million of losses in the consolidated results of Natura &Co.

Since the acquisition was concluded on 1 January 2020 and there was no significant transaction of the revenue results until 3 January 2020, the consolidated net profit and net revenue of the six-month period ended 6 June 2020 represents an impact on the Company’s net revenue and profit as if the acquisition had been made at the beginning of the year.

 

5.

FINANCIAL RISK MANAGEMENT

 

5.1

General considerations and policies

The information pertaining to the general considerations and policies of the companies of the Natura group, TBS and Aesop is presented in the 2019 annual financial statements in Note 5.

The book and fair values of the Company’s financial instruments as of 30 June 2020 are presented in the table below:

 

                        Book Value     Fair Value  

Controlling Company

   Note     

Classification by category

   Fair value
hierarchy
     06/2020     12/2019     06/2020     12/2019  

Financial assets

                 

Cash and cash equivalents

     6      Amortized cost            

Cash and banks

              113       2,173,101       113       2,173,101  

Certificate of bank deposits

              499,134       207,699       499,134       207,699  
           

 

 

   

 

 

   

 

 

   

 

 

 
              499,247       2,380,800       499,247       2,380,800  

Short-term investments

                 

Exclusive investment funds

     7      Fair value through results      Level 2        1,583,045       669,769       1,583,045       669,769  

Trade receivables - related parties

     32.1      Amortized cost         506,876       —         506,876       —    

Financial liabilities

                 

Borrowings in domestic currency

     19      Amortized cost         (1,073,162     (2,883,382     (1,073,162     (2,883,382

Trade payables, reverse factoring and related parties

     20      Amortized cost         (14,129     —         (14,129     —    

 

                        Book Value      Fair Value  

Consolidated

   Note     

Classification by category

   Fair value
hierarchy
     06/2020      12/2019      06/2020      12/2019  

Financial assets

                    

Cash and cash equivalents

     6                    

Cash and banks

      Amortized cost         2,872,297        3,110,220        2,872,297        3,110,220  

Certificate of bank deposits

      Amortized cost         766,703        211,261        766,703        211,261  

Repurchase operations

      Fair value through results      Level 2        1,181,116        1,192,101        1,181,116        1,192,101  
           

 

 

    

 

 

    

 

 

    

 

 

 
              4,820,116        4,513,582        4,820,116        4,513,582  

Short-term investments

     7                    

Government securities

      Fair value through results      Level 2        1,486,999        221,900        1,486,999        221,900  

Restricted cash

      Fair value through results      Level 2        58,764        —          58,764        —    

Financial letter

      Fair value through results      Level 2        377,033        374,690        377,033        374,690  

Mutual investment fund

      Fair value through results      Level 2        376,538        407,928        376,538        407,928  

Dynamo Beauty Ventures Ltd Fund

      Fair value through results      Level 2        11,326        7,402        11,326        7,402  

Certificate of bank deposits

      Fair value through results      Level 2        270,870        21,327        270,870        21,327  
           

 

 

    

 

 

    

 

 

    

 

 

 
              2,581,530        1,033,247        2,581,530        1,033,247  

Trade receivables

     8      Amortized cost         2,644,601        1,685,764        2,644,601        1,685,764  

Court deposit

     12      Amortized cost         600,340        337,255        600,340        337,255  

 

F-17


LOGO

 

“Financial” and “Operating” derivatives

      Fair value – Hedge instruments      Level 2        2,163,255       737,378       2,163,255       737,378  

“Financial” and “Operating” derivatives

      Fair value through results      Level 2        35,918       —         35,918      
           

 

 

   

 

 

   

 

 

   

 

 

 
              2,199,173       737,378       2,199,173       737,378  

Financial liabilities

                 

Borrowings, financing and debentures

   19               

Borrowings in domestic currency

      Amortized cost         (16,097,706     (7,412,443     (15,981,649     (7,445,672

Borrowings in foreign currency

      Amortized cost         (4,568,393     (3,373,931     (4,420,002     (3,541,541
           

 

 

   

 

 

   

 

 

   

 

 

 
              (20,666,099     (10,786,374     (20,401,651     (10,987,213

“Financial” and “Operating” derivatives

      Fair value – Hedge instruments      Level 2        —         (10,158     —         (10,158

“Financial” and “Operating” derivatives

      Fair value through results      Level 2        (75,247     (1,648     (75,247     (1,648
           

 

 

   

 

 

   

 

 

   

 

 

 
              (75,247     (11,806     (75,247     (11,806

Lease

   18    Amortized Cost         (4,107,175     (2,517,565     (4,107,175     (2,517,565

Trade payables and reverse factoring operations

   20    Amortized cost         (5,709,969     (1,829,756     (5,709,969     (1,829,756

 

5.2

Financial risk factors

Information pertaining to the financial risk factors is presented in the Company’s 2019 annual financial statements in Note 5.2.

 

  a)

Market risks

To hedge the current positions of the Balance Sheet of the Company and its subsidiaries against market risk, the following derivative financial instruments were used and consist of the following balances as of 30 June 2020 and 31 December 2019:

 

Description

   Fair Value (Level 2)  
   Consolidated  
   06/2020      12/2019  

“Financial” derivatives

     2,121,287        725,060  

“Operating” derivatives

     2,639        512  
  

 

 

    

 

 

 

Total

     2,123,926        725,572  
  

 

 

    

 

 

 

 

  b)

Foreign exchange risk

As of 30 June 2020 and 31 December 2019, the Company and its subsidiaries are primarily exposed to the risk of fluctuation of the US dollar, euro, pound sterling and emerging market currencies. In order to hedge foreign exchange exposures in relation to foreign currency, the Company and its subsidiaries enter into transactions with derivative financial instruments of the “swap” type and forward purchase of currency named Non-Deliverable Forwards (“NDFs”).

As of 30 June 2020, borrowings, financing and debentures in the consolidated balance sheet include accounts in foreign currency which expose the subsidiaries of the Company to foreign exchange risk, representing, in the aggregate, total liabilities of R$ 4,568,393 (R$ 3,381,959 as of 31 December 2019).

 

i)

Derivatives to hedge foreign exchange risk

The outstanding derivative agreements present maturity flows between January 2020 and February 2023. The derivative agreements in The Body Shop were entered into with represented counterparties and mature within up to 12 months.

The Company and its subsidiaries classify derivatives into: “Financial” and “Operating”. The “Financial” ones are “swap” or “forward” derivatives, contracted to hedge the foreign exchange risk of borrowings, financing, debt instruments and loans in foreign currency. The “Operating” ones are derivatives contracted to hedge the foreign exchange risk of operating cash flows of the business.

 

F-18


LOGO

 

As of 30 June 2020, the balances of derivatives are as follows:

“Financial” derivatives

 

Consolidated

   Principal
(Notional) amount
     Curve value     Fair value     Gain (loss) of adjustment
at fair value
 

Description

   06/2020      12/2019      06/2020      12/2019     06/2020     12/2019     06/2020     12/2019  

Swap agreements:

                   

Asset portion:

                   

Dollar purchased position

     2,661,494        2,664,001        4,603,592        3,416,707       5,102,622       3,729,691       499,030       312,984  

Liability portion:

                   

Post-fixed CDI Rate:

                   

Position sold in CDI

     2,661,494        2,664,001        2,729,070        2,754,595       2,942,841       3,002,623       213,770       248,028  
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

NDFs Forward Agreements:

                   

Liability portion:

                   

Post-fixed CDI Rate:

                   

Position sold at the interbank rate

     5,442,792        200,896        1,882        (1,848     (38,494     (2,008     (40,376     (160
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total net derivative financial instruments:

     5,442,792        200,896        1,876,404        660,264       2,121,287       725,060       244,884       64,796  
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

For financial derivatives maintained by the Company and its subsidiaries as of 31 December 2019 and 30 June 2020, due to the fact that the agreements are directly entered into with the financial institutions and not through stock markets, there are no margin calls deposited as guarantee of these transactions.

“Operating” derivatives - Consolidated

As of 30 June 2020, the Company and its subsidiaries maintain derivative financial instruments of the “forward” type, with the purpose of hedging the foreign exchange risk of operating cash flows (such as import and export transactions):

 

Description

   Principal (Notional) amount      Fair value  
   06/2020      12/2019      06/2020      12/2019  

Net position - GBP and USD

     1,093,241           5,898        —    

Forward agreements

     119,851        1,302,869        (3,259      512  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total Derivative Financial Instruments, net

     1,213,092        1,302,869        2,639        512  
  

 

 

    

 

 

    

 

 

    

 

 

 

Sensitivity analysis

For the sensitivity analysis of the foreign exchange exposure risk, the Management of the Company and its subsidiaries understands it is necessary to consider, in addition to the assets and liabilities with exposure to the fluctuation of exchange rates recorded in the balance sheet, the fair value of the financial instruments contracted by the Company to hedge certain exposures as of 30 June 2020, as shown in the following table:

 

     Consolidated  
     06/2020      12/2019  

Loans and financing in Brazil in foreign currency (a)

     (4,587,578      (3,381,959

Accounts receivable registered in Brazil in foreign currency

     11,727        10,007  

Accounts payable registered in Brazil in foreign currency

     (11,686      (10,543

Fair value of the “financial” derivatives

     5,102,622        3,729,691  
  

 

 

    

 

 

 

Net asset exposure

     515,085        347,196  
  

 

 

    

 

 

 

(a) Excluding transaction costs.

This analysis considers only financial assets and liabilities registered in Brazil in foreign currency, since foreign exchange exposure in other countries is close to zero due to the strength of currencies and the effectiveness of their derivatives, and considers that all other variables, especially interest rates, remain constant and ignore any impact from purchase and sale forecasts.

The tables below show the projection for incremental loss that would have been recognized in the subsequent period, assuming that the current net foreign exchange exposure remains static and based on the following scenarios:

 

     Consolidated  
Description    Company’s Risk      Probable scenario     Scenario II      Scenario III  

Net exposure

     Dollar decrease        (2,481     101,032        170,041  

 

F-19


LOGO

 

The probable scenario considers future US dollar rates for 90 days, as of 30 June 2020. According to quotations obtained at B3 on the expected maturity dates of financial instruments with foreign exchange exposure, it is R$ 5.45 / USD 1.00. Scenarios II and III consider a drop in the US dollar of 25% (R$ 4.09 / USD 1.00) and 50% (R$ 2.72 / USD 1.00), respectively. Probable scenarios II and III are being presented in compliance with CVM Ruling No. 475/08. The Management uses the probable scenario in the assessment of possible changes in the exchange rate and presents this scenario in compliance with IFRS 7/CPC 40 - Financial Instruments: Disclosures.

The Company and its subsidiaries do not use derivative financial instruments for speculative purposes.

Derivative instruments designated for hedge accounting

The positions of derivative financial instruments designated as outstanding cash flow hedge on 30 June 2020 are set out below:

Cash flow hedge instrument - Consolidated

 

            Other comprehensive income  
     Hedged
Item
     Notional
currency
     Notional
value
     Curve Value      Fair value      Retained
Earnings (Loss)

of the
agreement
     Earnings
in the
12-month
period
 

Currency Swap – USD/R$

     Currency        BRL        2,659,360        1,872,141        2,157,449        285,308        223,672  

Forward Agreements (The Body Shop)

     Currency        BRL        883,167        4,339        5,613        5,613        (198

Forward Agreements (Natura Indústria)

     Currency        BRL        39,713        —          193        193        5,482  
        

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

           3,582,240        1,876,480        2,163,255        291,114        228,956  
        

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Movements in cash flow hedge reserve recorded under other comprehensive income are shown below:

 

     Consolidated  

Cash flow hedge balance as of 31 December 2018

     (27,706

Change in the fair value of hedge instrument recognized in other comprehensive income

     159,698  

Tax effects on the fair value of hedge instrument

     (53,701
  

 

 

 

Cash flow hedge balance as of 30 June 2019

     78,291  
  

 

 

 

Cash flow hedge balance as of 31 December 2019

     42,729  
  

 

 

 

Change in the fair value of hedge instrument recognized in other comprehensive income

     228,956  

Tax effects on the fair value of hedge instrument

     (75,842
  

 

 

 

Cash flow hedge balance as of 30 June 2020

     195,843  
  

 

 

 

 

  c)

Interest rate risk

Sensitivity analysis

On 30 June 2020, there were borrowings, financing and debenture agreements in foreign currency attached to swap agreements, changing the indexation over the liability to the variation of the Certificate of Interbank Deposit (“CDI”). Therefore, the risk of the Company and its subsidiaries becomes the CDI variation exposure. The exposure to interest rate risk of transactions bound to CDI variation, including derivative transactions is set out in the table below (borrowings, financing and debentures were considered at their full amounts, since 98.42% of their sum is linked to CDI):

 

     Controlling
Company
     Consolidated  

Total loans and financing - in local currency (note No. 19)

     (1,073,162      (16,097,706

Operations in foreign currency with derivatives bound to CDI

     —          (4,568,393

Financial investments (explanatory notes 6 and 7)

     2,082,179        4,459,259  
  

 

 

    

 

 

 

Net exposure

     1,009,017        (16,206,840
  

 

 

    

 

 

 

The tables below show the projection for incremental loss that would have been recognized in the subsequent period, assuming that the current net liability exposure remains static and based on the following scenarios:

 

Consolidated

 

Description

   Company’s Risk      Probable
scenario
     Scenario II     Scenario III  

Net liability

     Rate increase        4,574        (29,406     (63,386

The probable scenario considers the future interest rates according to quotations obtained at B3 on the expected maturity dates of financial instruments with exposure to interest rates appraised on 30 June 2020. Scenarios II and III consider an increase of 25% (2.6% p.a.) and 50% (3.1% p.a.) on the interest rate, respectively, based on a CDI of 2.1%. p.a.

 

F-20


LOGO

 

d) Credit risk

The result of the credit risk management is reflected in line item “Provision for doubtful accounts” under “Trade receivables”, as demonstrated in explanatory note 8.

The Company and its subsidiaries consider the credit risk for transactions with financial institutions to be low, as these are considered by the Management as first-rate.

e) Liquidity risk

The Management monitors the consolidated liquidity level for the Company and its subsidiaries considering the expected cash flows against unused credit facilities, as shown in the following table:

 

     Controlling Company      Consolidated  
     06/2020      12/2019      06/2020      12/2019  

Total current assets

     2,591,364        3,050,574        17,064,524        9,430,057  

Total current liabilities

     (1,103,060      (3,080,906      (12,863,889      (7,518,423
  

 

 

    

 

 

    

 

 

    

 

 

 

Total net working capital

     1,488,304        (30,332      4,200,635        1,911,634  
  

 

 

    

 

 

    

 

 

    

 

 

 

As of 30 June 2020, the book value of financial liabilities on the date of the balance sheet, measured at amortized cost, considering interest payments at a post-fixed rate and the value of debt securities reflecting the forward market interest rates, may be changed as post-fixed interest rates change. Their corresponding maturities, considering that the Company and its subsidiaries are in compliance with contractual restrictive clauses, are set out below:

 

Controlling Company

   Less than
one year
     One to five
years
     Over five
years
     Total expected
cash flow
     Interest to
be accrued
    Book value  

Borrowings, financing and debentures

     1,115,106        —          —          1,115,106        (41,944     1,073,162  

Lease

                

Trade payables, reverse factoring and related-party trade payables

     13,799        —          —          13,799        —         13,799  

 

Consolidated

   Less than
one year
     One to five
years
     Over five
years
     Total expected
cash flow
     Interest to
be accrued
    Book value  

Borrowings, financing and debentures

     2,554,860        19,329,476        —          21,884,336        (1,218,237     20,666,099  

Lease

     1,272,171        2,883,814        1,014,375        5,170,360        (1,063,185     4,107,175  

Trade payables and reverse factoring operations

     5,709,969        —          —          5,709,969        —         5,709,969  

As of 31 December 2019, the Company and its subsidiaries had two credit facilities:

 

   

Up to seventy million pounds sterling (GBP 70 million), with no guarantee, that could be withdrawn in installments to meet short-term financing needs of The Body Shop International Limited. This facility was used by the indirect subsidiary during the first quarter of 2020 to reinforce working capital and liquidity.

 

   

Up to one hundred and fifty million Reais (R$ 150,000), with no guarantee, which was terminated during the first semester of 2020.

 

5.3

Impacts of Covid-19

Despite the level of uncertainty, the Company is closely monitoring the evolution of the pandemic caused by Covid-19 worldwide. To this end, Crisis Committees were created on several fronts, with the participation of key people in the organization, with the function of monitoring, analyzing and deciding on actions to minimize impacts, ensure the continuity of operations and promote the safety and health of all people involved.

Since the beginning of the virus spread and the consequent restrictive measures imposed by governments, such as closing non-essential trade and restricting the movement of people across borders, the Company has implemented some measures in all its operations, in line with the official measures:

 

  a.

Incentive to work remotely and adoption of essentiality criteria to limit industrial and logistical operations;

 

F-21


LOGO

 

  b.

Adoption of new safety measures for operational workers, such as the use of masks and procedures to distance people between processes;

 

  c.

Closure of stores, where required by the authorities;

 

  d.

Re-planning of sales cycles, prioritizing personal care items;

 

  e.

Speeding up the digitization of sales channels;

 

  f.

Wide dissemination of the digital magazine;

 

  g.

Change in the minimum order criteria, start kit and increased deadline for payment of consultants; and

 

  h.

Daily monitoring of suppliers to ensure supply.

In addition to these measures, there is a Crisis Committee focused on finance which monitors the Company’s financial health, with a focus on cash, covenants and results, proposing actions to minimize the inevitable reduction in sales. Among these actions, we find:

 

   

Reduction of discretionary expenses (consultancies, events, etc.);

 

   

Freezing of contracts and salary increases;

 

   

Reduction in marketing expenses;

 

   

Reductions in travel expenses;

 

   

Investment reduction (Capex);

 

   

Negotiation with suppliers to increase payment terms; and

 

   

Adherence to stimulus plans announced by the governments of some of the countries in which the Company operates.

During the period ended 30 June 2020, the impacts on the Company’s business were as follows:

 

   

Closing of stores: the Company and its subsidiaries have own stores and franchised stores distributed across its different brands and geographies that were impacted by lockdowns throughout the second quarter of 2020. At The Body Shop, lockdown restrictions led to the closure of 87% of retail stores at the end of April 2020, progressing to 16% of stores closed at the end of June 2020 with the restrictions flexibility. The Company and its subsidiaries were able to offset approximately 90% of the Covid-19 impact on sales through significant growth in online and At-Home channels and the gradual reopening of stores. At Aesop, during most of the second quarter of 2020, up to 90% of stores were closed across most markets. Nearly all of the Covid-19 impact on sales was offset with remarkable growth in digital sales and progressive reopening of stores. At Natura, all shopping mall stores were closed during most of the second quarter of 2020, and by the end of June, approximately 60% of all retail stores, including franchisee stores, were reopened, mostly with restrictions.

 

   

Production: In the beginning of the second quarter of 2020, Natura &Co quickly retooled operations across brands to step up production of essential products (such as soap and hand sanitizer) by over 30% of essential products capacity, by optimizing available capacity at Avon plants.

 

   

Cash and liquidity: the Company took steps to address liquidity concerns. R$2 billion was raised in a private placement, subscribed by Company’s controlling shareholders, selected investors and non-controlling shareholders. Also, R$750 million in new financing was raised, with maturity in May 2020, to increase liquidity with no impact on net debt. Strict cost discipline was adopted, including over capex and discretionary spending. The Company ended the second quarter of 2020 with a very strong cash position of R$4,820, resulting in further deleveraging and ensuring compliance with the financial covenants.

It is worth mentioning that the actions, decisions and the impacts mentioned in the financial statement are under constant review, according to the evolution of the global scenario.

 

5.4

Cyber incident

In June 2020, the Company became aware that it was exposed to a cyber incident in its Information Technology environment which interrupted some systems and partially affected operations. We engaged leading external cyber security and IT general controls specialists, launched a comprehensive containment and remediation effort and started a forensic investigation. As of the date of this report, the Company has re-established all of its core business processes and resumed operations in all of its markets, including all of its distribution centers. The Company continues to investigate and evaluate the extent of the cyber incident, while working diligently to mitigate its impacts and re-evaluate our IT general controls.

 

F-22


LOGO

 

The cyber incident had a significant impact on our revenue performance for the second quarter of 2020, with the majority of the impact being shifted to the third quarter of 2020 as the company fulfills the order backlog created. The incremental expense incurred as a result of the cyber incident in the second quarter of 2020 was not material.

 

6.

CASH AND CASH EQUIVALENTS

Information pertaining to cash and cash equivalents is presented in the Company’s 2019 annual financial statements in Note 6.

 

     Controlling Company      Consolidated  
     06/2020      12/2019      06/2020      12/2019  

Cash and banks

     113        2,173,101        2,872,297        3,110,220  

Certificate of Bank Deposits (a)

     499,134        207,699        766,703        211,261  

Repurchase operations (b)

     —          —          1,181,116        1,192,101  
  

 

 

    

 

 

    

 

 

    

 

 

 
     499,247      2,380,800      4,820,116      4,513,582  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(a)

As of 30 June 2020, investments in Certificate of Bank Deposits (“CDBs”) are remunerated at an average rate of 102.7% of CDI with daily maturities redeemable with the issuer itself, without significant loss of value.

(b)

Repurchase operations are securities issued by banks with a commitment by the bank to repurchase them, and by the client to resell them, at defined rates and within a predetermined term, backed by public or private securities, depending on bank availabilities and registered with the Central for the Custody and Financial Settlement of Securities (“CETIP”). On 30 June 2020, repurchase operations are remunerated at an average rate of 103.8% of CDI (106.9% of the CDI on 31 December 2019).

 

7.

SHORT-TERM INVESTMENTS

Information pertaining to short-term investments was presented in the Company’s 2019 annual financial statements in Note 7.

 

     Controlling Company      Consolidated  
     06/2020      12/2019      06/2020      12/2019  

Exclusive investment funds

     1,583,045        669,769        —          —    

Loan investment funds

     —          —          376,538        407,928  

Certificate of Bank Deposits (a)

     —          —          270,870        21,327  

Financial letters

     —          —          377,033        374,690  

Government securities (LFT)

     —          —          1,486,999        221,900  

Dynamo Beauty Ventures Ltd. Fund

     —          —          11,326        7,402  

Restricted cash

     —          —          58,764        —    
  

 

 

    

 

 

    

 

 

    

 

 

 
     1,583,045      669,769      2,581,530      1,033,247  
  

 

 

    

 

 

    

 

 

    

 

 

 

Current

     1,583,045        669,769        2,570,204        1,025,845  

Non-Current

     —          —          11,326        7,402  

 

(a)

As of June 30, 2020 the CDBs classified as short-term investments are remunerated at an average rate of 103.8% of CDI (106.9% of CDI as of 31 December 2019). The balance on 30 June 2020 related to the “Crer para Ver” line within the exclusive fund is R$ 35,423 (R$ 38,018 on 31 December 2019).

The breakdown of securities constituting the Essential Investment Fund portfolio on 30 June 2020 and 31 December 2019 is as follows:

 

     06/2020      12/2019  

Certificate of term deposits

     270,870        21,327  

Repurchase operations

     1,181,116        1,192,101  

Financial letters

     377,033        374,690  

Government securities (LFT)

     1,486,999        221,900  
  

 

 

    

 

 

 
     3,316,018      1,810,018  
  

 

 

    

 

 

 

 

8.

TRADE RECEIVABLES

Information pertaining to trade receivables was presented in the Company’s 2019 annual financial statements in Note 8.

 

     Consolidated  
     06/2020      12/2019  

Trade receivables

     3,109,500        1,793,759  

Provision for doubtful accounts

     (464,899      (107,995
  

 

 

    

 

 

 
     2,644,601      1,685,764  
  

 

 

    

 

 

 

 

F-23


LOGO

 

Maximum exposure to credit risk on the date of the financial statements is the book value of each maturity date range, net of the provision for doubtful accounts, as shown in the chart of receivable balances per maturity date:

 

     Consolidated  
     06/2020      12/2019  

To become due

     1,632,884        1,501,958  

Past due:

     

Up to 30 days

     928,674        142,069  

31 to 60 days

     182,119        36,466  

61 to 90 days

     83,788        27,789  

91 to 180 days

     282,035        85,477  

Provision for doubtful accounts

     (464,899      (107,995
  

 

 

    

 

 

 
     2,644,601      1,685,764  
  

 

 

    

 

 

 

Movements in the provision for doubtful accounts for the period ended 30 June 2020 are as follows:

 

     Consolidated  

Balance on 31 December 2018

     (129,242

Additions

     (118,037

Write-offs

     138,116  

Exchange variation

     471  
  

 

 

 

Balance on 30 June 2019

     (108,692
  

 

 

 

Balance on 31 December 2019

     (107,995

Control acquisition

     (270,187

Additions

     (397,409

Write-offs

     371,004  

Exchange variation

     (60,312
  

 

 

 

Balance on 30 June 2020

     (464,899
  

 

 

 

The balances of trade receivables per exposure to the risk of doubtful accounts on 30 June 2020 are set out below:

 

     Consolidated  
     Trade receivables      Provision for
doubtful accounts
 

To become due

     1,632,883        (46,358

Past due:

     

Up to 30 days

     928,674        (63,254

31 to 60 days

     182,119        (67,201

61 to 90 days

     83,788        (53,795

91 to 180 days

     282,026        (234,291
  

 

 

    

 

 

 
     3,109,500        (464,899
  

 

 

    

 

 

 

 

9.

INVENTORIES

Information pertaining to inventories was presented in the Company’s 2019 annual financial statements in Note 9.

 

     Consolidated  
     06/2020      12/2019  

Finished products

     3,847,372        1,253,145  

Raw materials and packaging

     1,030,020        253,063  

Auxiliary materials

     211,372        82,228  

Products in progress

     34,690        27,346  

Provision for losses

     (642,107      (185,232
  

 

 

    

 

 

 
     4,481,347        1,430,550  
  

 

 

    

 

 

 

 

F-24


LOGO

 

Movements in the provision for inventory losses for the period ended 30 June 2020 are as follows:

 

     Consolidated  

Balance on 31 December 2018

     (178,268
  

 

 

 

Net additions

     (72,980

Write-offs

     60,743  

Exchange variation

     2,139  
  

 

 

 

Balance on 30 June 2019

     (188,366
  

 

 

 

Balance on 31 December 2019

     (185,232
  

 

 

 

Control acquisition

     (332,350

Net additions

     (190,763

Write-offs

     166,520  

Exchange variation

     (100,282
  

 

 

 

Balance on 30 June 2020

     (642,107
  

 

 

 

 

10.

RECOVERABLE TAXES

Information pertaining to the Company’s recoverable taxes was presented in the 2019 annual financial statements in Note 10.

 

     Consolidated  
     06/2020      12/2019  

ICMS on purchase of inputs (a)

     671,227        434,832  

Taxes on purchase of inputs - subsidiaries abroad

     214,702        39,475  

ICMS on purchase of property, plant and equipment

     10,024        10,628  

PIS and COFINS on purchase of property, plant and equipment (b)

     179        3,826  

PIS and COFINS on purchase of inputs

     802,466        280,087  

PIS, COFINS and CSLL - withheld at source

     3,779        2,378  

IPI (Tax on Manufactured Products)

     83,828        30,190  

Others

     152,402        3,438  
  

 

 

    

 

 

 
     1,938,607        804,854  
  

 

 

    

 

 

 

Current

     1,045,201        395,640  

Non-Current

     893,406        409,214  

 

a)

Accumulated Brazilian tax on the circulation of goods, interstate and intercity transportations and communication services (“ICMS”) tax credits.

b)

Brazilian tax for the Integration Program Tax on Revenue (“PIS”) and Social Security Funding Tax on Revenue (COFINS).

 

11.

INCOME TAX AND SOCIAL CONTRIBUTION

The effective tax rate calculated by the Company for the period ended June 30, 2020 was negative 13.0%. This percentage is based on the loss before taxes of R$ 1,077.4 million and the resulting income tax expense of R$ 139.7 million. The main components causing the effective tax rate to differ from the statutory income tax rate of 34% are the losses of certain jurisdictions which cannot be benefited, permanent effects related to income tax withheld at source arising from transactions among companies of the group which cannot be applied as an income tax credit and the additional recognition of deferred tax liability due to the announcement by the British government that the statutory income tax rate will not be reduced from 19% to 17%. Excluding the adverse effects primarily caused by these noted components, the Company’s effective tax rate would be approximately 31.1%.

The effective rate calculated by the Company in the period ended June 30, 2019 was 30.7%. This percentage is based on the profit before taxes of R$ 100.1 million and the resulting income tax expenses of R$ 30.7 million. The main components causing the effective rate to differ from the statutory income tax rate of 34% are the tax incentives and the subvention of investments.

 

F-25


LOGO

 

Movements in deferred asset and liability income tax and social contribution for the period ended 30 June 2020 are as follows:

 

     Controlling
Company
     Assets      Liabilities  
     Consolidated      Consolidated  

Balance on 31 December 2018

     —          398,400        (431,534

Effect on results

     —          44,859        3,298  

Reserve for grant of options and restricted stock

     —          13,380         

Effect on other comprehensive income

     —          (53,701       

Exchange variation on other comprehensive income

     —          4,615        13,649  
  

 

 

    

 

 

    

 

 

 

Balance on 30 June 2019

     —          407,553        (414,587
  

 

 

    

 

 

    

 

 

 

Balance on 31 December 2019

     —          374,448        (450,561
  

 

 

    

 

 

    

 

 

 

Effect on results

     71,868        (22,022      (28,630

Control acquisition

     —          667,034        (713,199

Reserve for grant of options and restricted stock

     —          2,865        —    

Effect on other comprehensive income

     —          (75,842      —    

Exchange variation on other comprehensive income

     —          29,409        (221,081
  

 

 

    

 

 

    

 

 

 

Balance on 30 June 2020

     71,868        975,892        (1,413,471
  

 

 

    

 

 

    

 

 

 

 

12.

JUDICIAL DEPOSITS

Information pertaining to the Company’s judicial deposits was presented in the 2019 annual financial statements in Note 12.

 

     Consolidated  
     06/2020      12/2019  

Unprovisioned tax proceedings (a)

     296,529        203,403  

Provisioned tax proceedings (b) (notes 21 and 22)

     249,576        116,415  

Unprovisioned civil proceedings

     6,570        2,541  

Provisioned civil proceedings (note 22)

     2,505        426  

Unprovisioned labor proceedings

     14,330        8,683  

Provisioned labor proceedings (note 22)

     30,830        5,787  
  

 

 

    

 

 

 

Total judicial deposits

     600,340        337,255  
  

 

 

    

 

 

 

 

c)

The tax proceedings related to these judicial deposits are mainly related to ICMS-ST, highlighted in note 20 (a) - contingent liabilities - possible risk of loss.

d)

The tax proceedings related to these judicial deposits are mainly related to the sum of amounts disclosed in explanatory note 21, item (a) and the amounts provisioned pursuant to explanatory note 20.

Find below the movements in the balances of judicial deposits for the periods ended 30 June 2020 and 2019:

 

     Consolidated  

Balance on 31 December 2018

     333,577  
  

 

 

 

New deposits

     1,367  

Redemptions

     (1,362

Monetary adjustment

     7,447  

Write-offs for expenses

     (3,569
  

 

 

 

Balance on 30 June 2019

     337,460  
  

 

 

 

 

Balance on 31 December 2019

     337,255  
  

 

 

 

Control acquisition

     283,885  

New deposits

     7,911  

Redemptions

     (21,186

Monetary adjustment

     6,216  

Payments

     (10,070

Write-offs for expenses

     (3,671
  

 

 

 

Balance on 30 June 2020

     600,340  
  

 

 

 

In addition to judicial deposits, the Company and its subsidiaries have contracted guarantee insurance policies for some proceedings. Details of these insurance policies are presented in explanatory note No. 3.2.

 

F-26


LOGO

 

13.

ASSETS AVAILABLE FOR SALE

Assets classified as available for sale were acquired by Avon (Note 4). The following table shows the changes in the balance for the period ended 30 June 2020:

 

     Consolidated  

Acquisition by Avon on 3 January 2020

     186,518  

Transfer to property, plant and equipment(a)

     (39,186

Transfer from property, plant and equipment(b)

     16,210  

Sale

     (22,287

Exchange variation

     54,302  
  

 

 

 

Balance on 30 June 2020

     195,557  
  

 

 

 

 

a)

Avon has identified new circumstances which arose which were previously considered as unlikely and, as a result, Avon decided not to carry on with the sale of two properties. As a result, the subsidiary reclassified the properties available for sale into property, plant and equipment. During the reclassification, a real depreciation, resulting in a non-property impact to the consolidated financial statements, was recorded.

b)

Decision to sell one more property, which was previously classified as property, plant and equipment.

On 30 June 2020, the assets available for sale include two Avon properties at the sum of R$ 195,557.

 

14.

OTHER CURRENT AND NON-CURRENT ASSETS

 

     Consolidated  
     06/2020      12/2019  

Marketing and advertising advances

     99,545        28,669  

Supplier advances

     224,335        102,225  

Employee advances

     79,882        13,983  

Rent advances and guarantee deposit (a)

     133,448        96,202  

Advance insurance expenses

     170,277        29,647  

Overfunded pension plan( b)

     711,526        —    

Customs broker advances - Import taxes

     38,592        34,932  

Subleasing receivables (c)

     395,605         

Carbon credit

     3,799        3,508  

Others

     543,806        39,868  
  

 

 

    

 

 

 
     2,400,815        349,034  
  

 

 

    

 

 

 

Current

     799,222        265,198  

Non-Current

     1,601,593        83,836  

 

a)

This substantially refers to (i) advance payments for rental agreements that were not included in the initial measurement of lease liabilities/right-of-use of the subsidiary The Body Shop International Limited, in accordance with the exceptions permitted under CPC 06(R2) / IFRS 16; and (ii) guarantees for renting properties of certain stores of subsidiaries The Body Shop International Limited and Emeis Holdings Pty Ltd., which will be returned by the lessor at the end of the rental agreements.

b)

Pension plan arising from the Avon’s acquisition on 3 January 2020 (Note 4)

c)

This pertains to the sublease receivables from the office Avon had in New York.

 

15.

INVESTMENTS

 

     Controlling Company  
     06/2020      12/2019  

Investments in subsidiaries, net of losses

     10,713,042        3,392,677  

Goodwill Avon (Note 4)

     10,973,473        —    
  

 

 

    

 

 

 

Total

     21,686,515        3,392,677  
  

 

 

    

 

 

 

Information and movements of balances for the period ended 30 June 2020 and for the fiscal year ended 31 December 2019:

 

F-27


LOGO

 

     Natura
Cosméticos
S.A. (1)
    Avon
Products,
Inc.
    Natura &Co
International S.à
r.l.
    Total  

Percentage Interest

     100.00     100.00     100.00  

Shareholders’ equity of the subsidiaries

     5,740,749       (4,911,624     (214     828,91,  

Shareholders’ equity interest

     5,740,749       (4,911,624     (214     828,911  

Fair value adjustment of acquired assets and liabilities

     —         9,884,131       —         9,884,131  

Goodwill

     —         10,973,473       —         10,973,473  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

     5,740,749       15,945,980       (214     21,686,515  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net Profit/(Losses) for the period of the subsidiaries

     182,712       (1,319,077     (287     (1,136,652

Balances on 31 December 2019

     3,392,677       —         —         3,392,677  

Equity in subsidiaries

     182,712       (1,319,077     (287     (1,136,652

Exchange variation and other adjustments in the conversion of investments of the subsidiaries abroad

     1,646,060       3,980,018       16       5,626,094  

Effect of Hyperinflationary economy adjustment

     30,470       10,145       —         40,615  

Contribution by the controlling company for stock option plans granted to executive officers of the subsidiaries and other reserves net of tax effects

     35,713       —         —         35,713  

Hedge accounting, net of tax effects

     153,117       —         —         153,117  

Capital increase

     300,000       —         —         300,000  

Acquisition price

     —         13,274,894       57       13,274,951  
  

 

 

   

 

 

   

 

 

   

 

 

 

Balances on 30 June 2020

     5,740,749       15,945,980       (214     21,686,515  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(1)

The investment balance in the direct subsidiary Natura Cosméticos S.A. includes goodwill arising from the acquisitions of indirect subsidiaries TBS (R$ 1,832,248) and Aesop (R$ 133,601).

 

F-28


LOGO

 

16.

PROPERTY, PLANT AND EQUIPMENT

Information pertaining to the Company’s property, plant and equipment was presented in the 2019 annual financial statements in Note 15.

 

     Consolidated  
     Useful life range (years)      12/2019     Control acquisition      Additions     Write-offs     Impairment     Transfers     Exchange variation     06/2020  

Cost value:

                    

Vehicles

     2 to 5        45,578       25,789        128       (4,519           2,171       12,042       81,189  

Templates

     3        192,556              8       (19,713           4,690       8,065       185,606  

Tools and accessories

     3 to 20        11,974       52,410        4,362       (158           (876     12,721       80,433  

Facilities

     3 to 60        309,772       1,431        23       (3,428           3,298       10,922       322,018  

Machinery and accessories

     3 to 15        866,451       746,734        7,352       (925           45,638       171,314       1,836,564  

Improvements in third-party real properties (a)

     2 to 20        615,103       58,548        11,653       (1,177     (8,650     5,618       177,970       859,065  

Buildings

    
14 to
60
 
 
     386,957       1,168,837        3,484       1,590       324       20,246       293,891       1,875,329  

Furniture and utensils

     2 to 25        397,727       32,566        10,622       (1,012     (8,883     7,545       95,387       533,952  

Lands

     —          35,157       568,470              73             4,060       191,749       799,509  

IT equipment

     3 to 15        297,228       112,369        4,691       (494           12,550       85,224       511,568  

Other assets

     —                40,090                                14,086       54,176  

Projects in progress

     —          156,011       78,965        104,602       (526           (89,486     11,155       260,721  
     

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total cost

        3,314,514       2,886,209        146,925       (30,289     (17,209     15,454       1,084,526       7,400,130  
     

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Depreciation value:

                    

Vehicles

        (16,924            (12,932     2,174             (2,093     (3,524     (33,299

Templates

        (175,938            (4,824     19,684                   (172     (161,250

Tools and accessories

        (3,255            (20,769                 10       (2,451     (26,465

Facilities

        (167,362            (11,582     282             900       (3,269     (181,031

Machinery and accessories

        (416,736            (95,836     157             (1,072     (16,382     (529,869

Improvement in third-party property

        (267,371            (60,425     450             25       (68,175     (395,496

Buildings

        (101,785            (51,515                       (4,847     (158,147

Furniture and utensils

        (193,973            (44,342     612             (26     (43,546     (281,275

IT equipment

        (197,281            (47,588     37                   (30,091     (274,923

Other assets

                     (6,841                       (769     (7,610
     

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total depreciation

        (1,540,625            (356,654     23,396             (2,256     (173,226     (2,049,365
     

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Overall Total

        1,773,889       2,886,209        (209,729     (6,893     (17,209     13,198       911,300       5,350,765  
     

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

F-29


LOGO

 

17.

INTANGIBLE ASSETS

Information pertaining to the Company’s intangible assets was presented in the 2019 annual financial statements in Note 16.

 

     Consolidated  
     Useful life
range
(years)
     12/2019     Control acquisition      Additions     Write-offs     Reversal
(provision) of
impairment
     Transfers     Exchange
variation
    06/2020  

Cost value:

                     

Software

     2.5 to 10        1,313,090       291,239        65,382       (1,492     —          112,649       153,649       1,934,517  

Trademarks and patents (Defined useful life)

     24 to 25        116,805       517,592        —         —         —          —         220,524       854,921  

Trademarks and patents (Indefinite useful life)

     —          2,171,585       1,893,224        —         —         —          —         1,255,816       5,320,625  

Goodwill Avon (Note 4)

     —          —         10,973,474        —         —         —          —         3,855,691       14,829,165  

Goodwill Emeis Brazil Pty Ltd.

     —          100,237       —          —         —         —          —         33,364       133,601  

Goodwill The Body Shop International Limited

     —          1,434,369       —          8,039       —         —          —         388,384       1,830,792  

Goodwill acquisition of The Body Shop stores

     —          1,456       —          —                  1,456  

Relationship with retail clients

     10        1,987       —          —         —         —          —         656       2,643  

Goodwill (Indefinite useful life)

     —          17,801       —          —         —         —          6,996       2,697       27,494  

Goodwill (Defined useful life)

     3 to 18        12,447       —          —         —         1,065        (3,414     (1,043     9,055  

Relationship with franchisees and sub franchisees

     14 to 15        602,958       1,876,169        —         —         —          —         822,215       3,301,342  

Developed technology (by acquired subsidiary)

     —          —         1,131,573        —         —         —          —         397,595       1,529,168  

Other intangible assets

     2 to 10        110,288       —          41,452       —         —          (100,153     18,071       69,658  
     

 

 

   

 

 

    

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Total cost

        5,883,023       16,683,271        114,873       (1,492     1,065        16,078       7,147,619       29,844,437  
     

 

 

   

 

 

    

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Amortization value:

                     

Software

        (649,347     —          (179,508     43       —          (3,634     (39,399     (871,845

Trademarks and patents

        (44,108     —          (18,303     —         —          —         (12,810     (75,221

Goodwill

        (2,197     —          (242     —         —          (4,634     1,213       (5,860

Relationship with retail clients

        (1,939     —          (114     —         —          —         (531     (2,584

Relationship with franchisees and sub franchisees

        (95,772     —          (147,980     —         —          —         (41,555     (285,307

Developed technology (by acquired subsidiary)

        —         —          (137,361     —         —          —         (15,419     (152,780

Other intangible assets

        (13,159        (1,042     —         —          —         (5,390     (19,591
     

 

 

   

 

 

    

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Total accrued amortization

        (806,522     —          (484,550     43       —          (8,268     (113,891     (1,413,188
     

 

 

   

 

 

    

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Net total

        5,076,501       16,683,271        (369,677     (1,449     1,065        7,810       7,033,728       28,431,249  
     

 

 

   

 

 

    

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

 

F-30


LOGO

 

18.

RIGHT OF USE AND LEASE

Information pertaining to the Company’s right of use and lease is presented in the 2019 annual financial statements in Note 17.

 

  a)

Right of use

 

            Consolidated  
     Useful life
range (years) (i)
     12/2019     Control
acquisition
     Additions     Write-offs     Transfers (a)     Exchange variation     06/2020  

Cost value:

                  

Vehicles

     3        40,018       42,467        46,577       (219     —         11,435       140,278  

Machinery and equipment

     3 to 10        15,578       14,034        610       —         —         8,958       39,180  

Buildings

     3 to 10        784,900       489,739        90,560       (4,380     —         211,050       1,571,869  

IT equipment

     10        283       18,429        1,447       —         —         5,751       25,910  

Retail stores

     3 to 10        2,350,377       —          180,059       (8,309     (3,582     767,063       3,285,608  

Tools and accessories

     3        2,803       —          —         —         —         761       3,564  
     

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total cost

        3,193,959       564,669        319,253       (12,908     (3,582     1,005,018       5,066,409  
     

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Depreciation value:

                  

Vehicles

        (8,109     —          (25,316     150       —         (2,236     (35,511

Machinery and equipment

        (4,317     —          (7,142     —         —         (2,036     (13,495

Buildings

        (97,190     —          (144,715     2,852       —         (27,349     (266,402

IT equipment

        (214     —          (10,320     —         —         (1,100     (11,634

Retail stores

        (463,332     —          (300,558     4,016       4,634       (172,458     (927,698

Tools and accessories

        (936        (462     —         —         (298     (1,696
     

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total accrued depreciation

        (574,098     —          (488,513     7,018       4,634       (205,477     (1,256,436
     

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net total

        2,619,861       564,669        (169,260     (5,890     1,052       799,541       3,809,973  
     

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

a.

Regarding the goodwill paid in store rentals, this transferred to intangible assets when a new commercial agreement with the lessor is signed.

 

F-31


LOGO

 

     Consolidated  
     06/2020      06/2019  

Values recognized in the income statement during the periods ended 30 June 2020 and 30 June 2019

     

Financial expense on lease

     119,398        64,137  

Amortization of right of use

     488,513        271,591  

Appropriation in the result of variable lease installments not included in the measurement of lease liabilities

     15,013        14,023  

Sublease revenue

     (16,033      (1,331

Short-term lease expenses and low-value assets

     38,274        78,774  

Advantages granted by lessor related to Covid-19

     (12,685      —    

Other expenses related to leases

     17,497        9,933  
  

 

 

    

 

 

 

Total

     649,977        437,127  
  

 

 

    

 

 

 

Values recognized in the financing cash flow statement

     

Payment of lease (principal amount)

     426,154        273,681  

Values recognized in the operating cash flow statement

     

Payment of lease (interest)

     88,443        75,259  

Variable lease payments not included in the measurement of lease liabilities

     4,448        8,100  

Short-term lease payments and low-value assets

     30,699        978  

Other lease-related payments

     20,174        15,985  
  

 

 

    

 

 

 

Total

     569,918        374,003  
  

 

 

    

 

 

 

 

  b)

Lease

 

     Consolidated  
     06/2020      12/2019  

Current

     1,081,059        542,088  

Non-Current

     3,026,116        1,975,477  
  

 

 

    

 

 

 

Total

     4,107,175        2,517,565  
  

 

 

    

 

 

 

The following table shows the changes in the balance of lease for the period ended 30 June 2020:

 

     Consolidated  

Balance on 31 December 2019

     2,517,565  

New agreements

     324,878  

Control acquisition

     777,200  

Payments - principal amount

     (380,902

Payments - interest

     (133,695

Financial charges appropriated

     119,398  

Write-offs (i)

     (3,863

Exchange variation

     886,594  
  

 

 

 

Balance on 30 June 2020

     4,107,175  
  

 

 

 

 

  i)

Mainly related to termination of agreements related to lease of stores.

The maturities of the balance of non-current lease liabilities are shown below:

 

     Consolidated  
     06/2020      12/2019  

2021

     441,760        374,746  

2022

     428,033        361,688  

2023

     422,877        358,274  

2024 onwards

     1,733,446        880,769  
  

 

 

    

 

 

 

Total

     3,026,116        1,975,477  
  

 

 

    

 

 

 

 

F-32


LOGO

 

19.

BORROWINGS, FINANCING AND DEBENTURES

Information pertaining to the Company’s borrowings, financing and debentures was presented in the 2019 annual financial statements in Note 18.

 

     Controlling Company      Consolidated  
     06/2020      12/2019      06/2020      12/2019  

Local Currency

           

Financing Agency for Studies and Projects (FINEP)

     —          —          87,617        101,988  

Debentures

     —          —          4,171,432        4.251,231  

BNDES

     —          —          17,451        35,390  

BNDES – FINAME

     —          —          46        183  

Promissory Notes

     1,073,162        2,883,382        1,322,889        2,883,382  

Working capital – Operation Mexico

     —          —          24,219        31,802  

Working capital – Operation Peru

     —          —          23,271     

Working capital – Operation Aesop

     —          —          98,559        100,438  

Working capital – Operation The Body Shop

     —          —          477,770        —    

Working capital – Operation Avon

     —          —          154,198        —    

Notes – Avon (1)

     —          —          9,720,254        —    
  

 

 

    

 

 

    

 

 

    

 

 

 

Total in local currency

     1,073,162        2,883,382        16,097,706        7,404,414  
  

 

 

    

 

 

    

 

 

    

 

 

 

Foreign Currency

           

BNDES

     —          —          4,721        8,029  

Export Credit note (NCE)

     —          —          110,148        81,210  

Notes (1)

     —          —          4.179,182        3,090,490  

Resolution No. 4131/62

     —          —          274,342        202,231  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total in foreign currency

     —          —          4,568,393        3,381,960  
  

 

 

    

 

 

    

 

 

    

 

 

 

Overall total

     1,073,162        2,883,382        20,666,099        10,786,374  
  

 

 

    

 

 

    

 

 

    

 

 

 

Current

     1,073,162        2,883,382        2,631,068        3,354,355  

Non-Current

     —          —          18,035,031        7,432,019  

(a) Debentures

           

Current

     —          —          164,555        246,017  

Non-Current

     —          —          4,006,877        4,005,214  

 

(1)

Balances recorded for their estimated fair value resulting from business combination with Avon (Note 4).

Changes in the balances of borrowings, financing and debentures for the periods ended 30 June 2020 and 2019 are presented below:

 

     Controlling
Company
     Consolidated  

Balance on 31 December 2018

     —          7,994,145  
  

 

 

    

 

 

 

Funding

     —          294,842  

Amortizations

        (594,912

Financial charges appropriated

     —          253,304  

Payment of financial charges

     —          (260,098

Exchange variation (unrealized)

     —          (86,954

Exchange variation (realized)

     —          2,814  

Effects of the conversion (other comprehensive income)

     —          583  
  

 

 

    

 

 

 

Balance on 30 June 2019

     —          7,603,724  
  

 

 

    

 

 

 

Balance on 31 December 2019

     2,883,382        10,786,374  
  

 

 

    

 

 

 

Control acquisition

            7,250,735  

Funding

     500,000        1,341,538  

Amortizations

     (2,326,905      (2.485,231

Financial charges appropriated

     38,363        557,122  

Payment of financial charges

     (21,678      (535,568

Exchange variation (unrealized)

            1,101,306  

Exchange variation (realized)

            3,889  

Effects of the conversion (other comprehensive income)

            2,645,934  
  

 

 

    

 

 

 

Balance on 30 June 2020

     1,073,162        20,666,099  
  

 

 

    

 

 

 

 

F-33


LOGO

 

Maturities of the registered installment of non-current borrowings, financing and debentures liabilities are as follows:

 

     Controlling Company      Consolidated  
     06/2020      12/2019      06/2020      12/2019  

2021

     —          —          2,253,221        —    

2022

     —          —          5,450,177        2,279,759  

2023

     —          —          6,644,547        527,596  

2024 onwards

     —          —          3,687,086        4,624,664  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

     —          —          18,035,031        7,432,019  
  

 

 

    

 

 

    

 

 

    

 

 

 

A description of the main bank borrowings and financing agreements in the period ended 30 June 2020 is as follows:

 

19.1

Description of the main movements of bank borrowings and financing

i) Promissory notes

On 14 January 2020, there was a partial optional early redemption of the Commercial Notes related to the first series in the amount of R$ 1,830 million.

On 29 April 2020, there was the 2nd issue of Commercial Promissory Notes by Natura Holding, in a single series in the amount of R$ 500 million, and the 4th issue of Commercial Promissory Notes, in a single series in the amount of R$ 250 million. The Commercial Notes were publicly distributed with restricted placement efforts, pursuant to CVM Ruling No. 476 of 16 January 2009. The allocation of funds went to the reinforcement of cash and liquidity.

On 29 June 2020, there was the total optional early redemption of the 1st issue of Commercial Notes by Natura Holding of the first series in the amount of R$ 370 million and the partial optional early redemption of the 1st issue of Commercial Notes of the second series in the amount of R$ 140 million.

The appropriation of costs related to the issuance of promissory notes during the period ended 30 June 2020 was R$ 19,461 (R$ 11,135 as of 31 December 2019), recorded monthly in the financial expenses, in accordance with the effective interest rate method. Issuance costs to appropriate totaled R$ 7,866 as of 30 June 2020 (R$ 20,962 as of 31 December 2019).

ii) Working capital – The Body Shop

As presented in the note of financial liquidity risk management (5.2.e), The Body Shop had, on 31 December 2019, a credit facility of up to seventy million pounds sterling (GBP 70 million), with no guarantee, that could be withdrawn in installments to meet short-term financing needs of The Body Shop International Limited. This facility was used by the indirect subsidiary during the second quarter of 2020, to reinforce working capital and liquidity, with annual interest payment of Libor + 2%.

iii) Working capital – Operation Peru

On 5 June 2020, the Company’s subsidiary raised, for reinforcement of working capital and liquidity, an amount of Peruvian soles 15 million, approximately R$ 22 million, with annual interest rate of 4.24% and maturity on 2 December 2020.

iv) Notes - Avon

Avon has issued the following notes:

 

Notes – Avon    Principal (USD)      Principal (R$)      Annual
interest rate
    Maturity  

No guarantee

     461,883        2,529,271        5.00     15 March 2023  

No guarantee

     243,847        1,335,306        6.95     15 March 2043  

With guarantee

     500,000        2,738,000        7.88     15 August 2022  

With guarantee

     400,000        2,190,400        6.50     15 August 2022  

To the Notes issued by Avon, add the effects of allocation of fair values from the business combination (Note 4), which amounted to R$ 779,497 as of 30 June 2020.

 

19.2

Restriction clauses of agreements

The contractual restriction clauses establish financial indexes arising from the quotient of the net treasury debt division by the earnings before interest, taxes, depreciation and amortization (“EBITDA”) of the last 12 months, which should be equal to or lower than what was established. The Company and its subsidiaries comply with such clauses as of the base date.

 

F-34


LOGO

 

20.

TRADE PAYABLES AND REVERSE FACTORING OPERATIONS

Information pertaining to the Company’s trade payables and reverse factoring operations was presented in the 2019 annual financial statements in Note 19.

 

     Controlling Company      Consolidated  
     06/2020      12/2019      06/2020      12/2019  

Domestic trade payables

     1,875        —          4,593,288        1,581,759  

Foreign trade payables

     11,924        —          861,849        105,073  
  

 

 

    

 

 

    

 

 

    

 

 

 
     13,799           5,455,137      1,686,832  
  

 

 

    

 

 

    

 

 

    

 

 

 

Reverse factoring operations

     —          —          254,832        142,924  
  

 

 

    

 

 

    

 

 

    

 

 

 
     13,799           5,709,969      1,829,756  

 

21.

TAX OBLIGATIONS

 

     Controlling Company      Consolidated  
     06/2020      12/2019      06/2020      12/2019  

Ordinary ICMS

        —          120,393        120,300  

ICMS-ST (a)

        —          61,926        72,423  

Taxes on sales result – subsidiaries abroad

        —          296,430        145,992  

Social Security Tax (INSS) - suspension of the enforceability

        —          —          50,147  

Taxes withheld at the source

     403        987        110,084        48,593  

Other taxes - subsidiaries abroad

        —          2,987        1,180  

Income Tax (IR)

     101        63        101        1,207  

INSS and ISS

        —          54,371        3,218  

Others

        —          77,355        399  
  

 

 

    

 

 

    

 

 

    

 

 

 
     504      1,050      723,647      443,459  
  

 

 

    

 

 

    

 

 

    

 

 

 

Judicial deposits

        —          (54,909      (62,356
     

 

 

    

 

 

    

 

 

 

Current

     504        1,050        614,839        320,890  

Non-Current

     —          —          108,808        122,569  

 

(a)

The Company’s subsidiaries have been discussing the illegality of changes in the state legislation for the payment of ICMS - ST. Part of the unpaid amount has been discussed in court by the Company and, in certain cases, the amounts have been deposited with the courts, as mentioned in explanatory note 12.

 

22.

PROVISION FOR TAX, CIVIL AND LABOR RISKS

Information pertaining to provision for the Company’s tax, civil and labor risks was presented in the Company’s 2019 annual financial statements in Note 21.

This provision is broken down as follows:

 

     Consolidated  
     06/2020      12/2019  

Tax

     876,036        127,842  

Civil

     180,491        30,653  

Labor

     257,241        61,571  
  

 

 

    

 

 

 

Total

     1,313,768        220,066  
  

 

 

    

 

 

 

Judicial deposits

     (228,002      (60,272
  

 

 

    

 

 

 

Current

     127,825        18,650  

Non-Current

     1,185,943        201,416  

 

F-35


LOGO

 

22.1

Contingencies with probable losses

The movement of the provision for tax, civil and labor risks and contingent liabilities is presented below:

 

     Consolidated  
     Tax     Civil     Labor  
     Provision     Deposits     Provision     Deposits     Provision     Deposits  

Balance at beginning of year

     127,842       (54,059     30,653       (426     61,571       (5,787

Control acquisition (1)

     657,647       (155,219     51,263       (4,898     164,091       (27,329

Additions

     78,727       (198     99,774       (2,648     21,388       (5,362

Reversals

     (29,946     10,208       (24,371     1,022       1,105       2,546  

Payments

     (52,412     —         (10,703     3,549       (21,470     5,244  

Monetary adjustment

     2,274       (2,516     2,802       (10     3,553       (92

Exchange variation

     92,145       2,533       31,103       344       26,166       263  

Other movements

     (241     4,584       (30     562       837       (313
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance on 30 June 2020

     876,036       (194,667     180,491       (2,505     257,241       (30,830
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(1)

Balances recorded for their estimated fair value resulting from business combination with Avon (Note 4).

 

22.2

Contingencies with possible losses

The Company and its subsidiaries have contingencies of a labor and social security, civil and tax nature, which expectation of loss assessed by the Management and supported by the legal advisers is classified as possible and, therefore, no provision has been constituted. The total sum under discussion rated as possible, due to the nature of the claims, is evidenced below:

 

     Consolidated  
     06/2020      12/2019  

Tax

     8,715,657        3,503,392  

Civil

     144,151        61,532  

Labor

     208,062        77,295  
  

 

 

    

 

 

 

Total contingent liabilities

     9,067,870        3,642,219  
  

 

 

    

 

 

 

Judicial deposits

     (242,817      (136,258
  

 

 

    

 

 

 

The main tax cases are the following:

 

  (i)

Infraction notices in which the Brazilian Federal Revenue Office collects IPI tax debts for the supposed lack of compliance with the minimum calculation basis set forth in the legislation, upon the sales transactions directed to interdependent wholesale establishments. Currently, judgment of the proceedings is awaited at the administrative level. On 30 June 2020, the total amount under discussion classified as possible loss is of R$1,951,431.

 

  (ii)

Court decisions which discuss the equivalence to industrial set forth in Decree No. 8,393/2015, which started requiring IPI in exit operations carried out by interdependent wholesale establishments of the products mentioned in said legal provision. On 30 June 2020, the amount under discussion is R$ 1,533,078 (R$ 389,017 as of 31 December 2019).

 

  (iii)

Administrative and court proceedings discussing the illegality of changes in the state legislation for the payment of ICMS and ICMS—ST. On 30 June 2020, the total amount under discussion is R$ 1,458,918 (R$ 406,002 as of 31 December 2019).

 

  (iv)

Infraction notices where the Brazilian Federal Revenue Office collects IRPJ and CSLL tax debts, in order to question the tax deductibility of goodwill amortization in the context of a corporate reorganization among related parties. Currently, there is discussion in the Judiciary Branch regarding the lawfulness of administrative decisions which rejected the motion to clarify, submitted to question the dismissed special appeals. On 30 June 2020, the total amount under discussion classified as possible loss is R$ 1,390,597 (R$ 1,379,189 as of 31 December 2019).

 

  (v)

Infraction Notice in which the State of São Paulo Treasury Office enforces the ICMS-ST collection, fully paid by the destination of the goods, the distributing establishment. Judgment of the proceedings is awaited at the administrative level. On 30 June 2020, the total amount under discussion classified as possible loss is R$ 526,933 (R$ 521,903 as of 31 December 2019).

 

  (vi)

Infraction notices in which the Brazilian Federal Revenue Service collects IPI tax debts due to disagreement with the tax classification adopted for some products. Judgment of the proceedings is awaited at the administrative level. On 30 June 2020, the total amount under discussion is R$ 296,898 (R$ 218,204 as of 31 December 2019).

The main civil cases are the following:

 

  i)

Avon was named defendant in several proceedings for personal damages filed in US courts, claiming that certain powder products that Avon sold in the past were contaminated with asbestos. Many such actions involve several co-defendants from a range of different industries, including cosmetics manufacturers and

 

F-36


LOGO

 

  manufacturers of other products that, unlike the Company’s products, were designed to include asbestos. On 30 June 2020, there were 139 individual proceedings pending against the subsidiary. During the six-month period ended 30 June 2020, 11 new proceedings were shelved and 20 others were shelved, settled or otherwise concluded. The amount of our records in this area so far has not been significant, whether individually or jointly. Similar additional cases deriving from the use of the subsidiary’s powder products are reasonably predicted.

We believe that the claims against us in such cases have no grounds. We are defending ourselves against these claims and to date, the subsidiary has not been sued in any case filed against it and there have been no findings of enforceable liability against the subsidiary. However, the results of testing throughout the country in similar cases filed against other manufacturers of cosmetic powder products vary from direct employment terminations to very large jury-led indemnifications for compensatory and punitive damages. Due to the uncertainties inherent to litigation, we cannot predict the results of all individual cases pending against the subsidiary, and we may only make a reasonable estimate for a small number of individual cases that have progressed to the later stages of court proceedings. For the remaining cases, we supply an aggregate and continuous exposure estimate, which considers the historic results of all cases we have settled so far. Any additions currently recorded in the subsidiary’s balance sheet in relation to these cases are not relevant. Other than those, currently, we may not estimate our reasonably possible or probable losses. However, any adverse results, whether in an individual case or jointly, may be relevant. The future costs to litigate such cases, which we fund when incurred, are unknown, but may be significant, although some costs are covered by insurance.

 

  ii)

On 14 February 2019, an alleged class action complaint of the shareholder (Bevinal v. Avon Products, Inc., et al., No. 19-cv-1420) was filed in the Southern District of New York against the Company and some of its former officers. On 3 June 2019, the court appointed a main plaintiff and a class attorney. The complaint was subsequently changed on 28 June 2019, retitled “In re Avon Products, Inc. Litigation over Securities” on 8 July 2019. On 24 July 2019, the plaintiffs presented a new changed complaint. The changed complaint was submitted on behalf of a new class, supposedly comprised of all purchasers or acquirers of Avon common shares between 21 January 2016 and 1 November 2017, including the latter date. The charge claims violations of Sections 10 (b) and 20 (a) of the 1934 Securities Exchange Act, based on supposedly fake or misleading statements and supposed market manipulation with relation to, among other things, changes made in Avon’s credit terms for Brazilian Representatives. On 26 July 2019, Avon and the individual defendants submitted a motion to dismiss. On 18 November 2019, the court denied this motion. Subsequently, on 16 December 2019, Avon and the individual defendants submitted an answer to the changed complaint. On 14 February 2020, the plaintiffs submitted a motion for class certification. The parties reached a settlement on the solution of this class action. The terms of the settlement include releases from class members of the complaints against the Company and the individual defendants and payment of USD 14.5 million (approximately R$ 79 million). Approximately USD 3 million (R$ 16 million), of the settlement shall be paid by the Company (that represents the remaining franchise under the applicable insurance policies of the Company) and the remainder of the settlement shall be paid by the Company’s insurers. Some documents related to the settlement still have not been finalized and the settlement is subject to court approval. If the settlement is not approved by the court, that is, it is rescinded before it is finalized, the Company will not be able to predict the result of this case. In addition, in this case, it is reasonably possible that the Company will incur in a loss related to this matter, which the Company cannot reasonably estimate.

 

22.3

Contingent assets

The updated amounts involved in the restitution requests of the PIS and COFINS installments paid with the inclusion of ICMS in their tax bases, not registered until 30 June 2020, amount to R$ 132,653 (R$ 26,933 as of 31 December 2019).

 

F-37


LOGO

 

23.

OTHER LIABILITIES

Information pertaining to other liabilities was presented in the Company’s 2019 annual financial statements in Note 22.

 

     Consolidated  
     06/2020      12/2019  

Post-employment medical assistance plan (a)

     777,228        98,792  

Carbon credit

     6,386        4,519  

Exclusivity contract

     4,200        5,400  

Crer para Ver

     52,427        51,543  

Deferred revenue from performance obligations with customers

     349,470        76,250  

Provision for sundry expenses

     275,147        156,895  

Provision for rentals

     40,363        26,568  

Provision for apportionment of benefits and partnerships payable

     5,426        7,860  

Long-term incentive

     286,595        3,022  

Provision for restructuring

     101,212        3,401  

Provision for store renovation

     85,469        15,997  

Other provision

     313,310        67,846  

Discontinued operations (b)

     94,840        —    

Professional fees

     95,782        —    
  

 

 

    

 

 

 

Total

     2,487,855        518,093  
  

 

 

    

 

 

 

Current

     1,322,558        396,391  

Non-Current

     1,165,297        121,702  

 

(a)

As of 30 June 2020, there is R$674.514 related to pension plans assumed in the Avon’s acquisition on 3 January 2020 and R$102.714 related to Natura’s pension plan (R$98.792on 31 December 2019).

(b)

On 17 December 2015, Avon entered into agreements resulting in the splitting of operations in the US, Canada and Puerto Rico. These transactions were terminated on 1 March 2016. From this date, the contingent liabilities prior to this transaction and related to the operations in the US, Canada and Puerto Rico are treated as discontinued operations. During the period ended 30 June 2020, Avon registered R$ 48,723 in administrative expenses pertaining to this provision.

 

24.

SHAREHOLDERS’ EQUITY

Information pertaining to the shareholder’s equity of the Company was presented in the 2019 annual financial statements in Note 23.

 

24.1

Capital stock

As of 30 June 2020, the Company’s capital stock is R$ 6,917,037, composed of 1,251,239,759 registered common shares without par value.

The composition of this capital is set out in the table below:

 

Date

  

Description

   Number of shares      Value in R$  

31/12/2019

   Total paid-up capital stock      865.659.942        1,485,436,464  

03/01/2020

   Capital increase      321,830,266        3,397,745,864  

15/03/2020

   Issue of new stock for stock option plans and restricted stock      780,808        21,936,005  

05/05/2020 to 30/06/2020

   Issue of new stock for stock option plans and restricted stock      621,653        16,811,439  

01/06/2020 to 30/06/2020

   Capital increase      62,347,090        1,995,106,880  
     

 

 

    

 

 

 

30/06/2020

   Total paid-up capital stock      1,251,239,759        6,917,036,652  
     

 

 

    

 

 

 

On January 3, 2020, 321,830,266 common shares were issued at an average price of 32.24 totaling R$ 3,397,746. On June 30, 62,347,090 common shares were issued at an average price of R$32.00 totaling R $ 1,995,107.

The Extraordinary Shareholders Meeting held on September 17, 2019 unanimously approved an increase in the Company’s capital by R$1,242,165, from R$468,973 to R$1,711,138, through a bonus share issue by capitalizing a portion of the balance in the earnings reserve, in accordance with article 169 of the Brazilian Corporations Law, with the issue of four hundred thirty-two million, five hundred seventy-one thousand, two hundred twenty-eight

 

F-38


LOGO

 

(432,571,228) book-entry, registered common shares with no par value, distributed to the shareholders of the Company as bonus shares in the proportion of one (1) new share for one (1) common share held. Thus, the number of shares increased from 432,571,228 to 865,142,456, all book-entry, registered common shares with no par value. This change in the proportion of Natura Cosméticos common shares changed the comparative information on earnings per share and share-based payments in this Company’s interim financial information.

 

24.2

Treasury shares

On 30 June 2020, the item “Treasury shares” had the following composition:

 

     Number of shares      R$ (in thousands)      Average price per
share—R$
 

Balance on 31 December 2019

     —          —          —    
  

 

 

    

 

 

    

 

 

 

Used

     (740,697      (40,981      55.33  
  

 

 

    

 

 

    

 

 

 

Acquisition

     1,114,460        54,936        49.29  
  

 

 

    

 

 

    

 

 

 

Balance on 30 June 2020

     373,763        13,955        37.34  
  

 

 

    

 

 

    

 

 

 

The minimum and maximum treasury share balance on 30 June 2020 is R$ 29.75 and R$ 49.71, respectively.

 

24.3

Capital reserve

Completion of the Avon acquisition resulted in the issue of Natura &Co shares for the total subscription price of R$ 13,274,894. Of this total, the amount of R$ 3,397,746 was allocated to the capital stock account and the rest, in the amount of R$ 9,877,148, was allocated to the Company’s capital reserve. This share merger was approved at a meeting of the Board of Directors on 3 January 2020.

The capital reserve also decreased due to the allocation of the special reserve to the profit reserve (R$ 147,592), an increase of R$ 26,679, due to the effects of CPC 42/IAS 29—Financial Reporting in Hyperinflationary Economies and decrease of R$ 22,063 regarding the movement of stock option and restricted stock plans.

The capital reserve amounts to R$ 11,037,162 as of 30 June 2020 (R$ 1,302,990 as of 31 December 2019).

 

24.4

Profit reserve

On 30 June 2020, the profit reserve increased R$ 151,384 due to: (i) the effects of “CPC 42/IAS 29—Financial Reporting in Hyperinflationary Economies” applied to the balances up to 30 June 2020, and (ii) R$ 147,592 regarding the reclassification arising from the special reserve.

 

25.

BUSINESS SEGMENT INFORMATION

The setup of the Company’s operating segments is based on its Corporate Governance structure, which splits the business for the purposes of decision-making and management analysis.

Since 3 January 2020, as a result of acquiring Avon (Note 4), the Management has the following Corporate Governance structure:

 

   

Operation Natura &Co Latam – all operations of Natura, Avon, Aesop and TBS located in Brazil and Latin America;

 

   

Avon International – all Avon operations, except those located in Brazil and Latin America;

 

   

TBS International – all The Body Shop operations, except those located in Brazil and Latin America; and

 

   

Aesop International – all Aesop operations, except those located in Brazil and Latin America.

In addition to the analysis per segment, the Company’s Management also assesses its revenues at several levels, mainly through sales channels: direct sales, operations in the retail market, e-commerce, B2B and franchises. However, segregation by this type of operation is not yet considered significant for disclosures by Management.

Net revenue by segment is as follows in the six-month period ended 30 June 2020:

 

   

Natura &Co Latam – 56%

 

   

Avon International – 26%

 

   

TBS International – 13%

 

   

Aesop International – 5%

 

F-39


LOGO

 

The accounting practices for each segment are described in explanatory note 3 of these financial statements of the Company for the year ended 31 December 2019.

The tables below present summarized financial information for the segments and the geographic distribution of commercial operations of the Company as of 30 June 2020, 31 December 2019 and 30 June 2019. In addition, as described above, because of the Avon acquisition in 2020, the Company changed the corporate governance structure, and consequently the segment disclosures. Thus, the comparative figures originally disclosed in the 2019 financial statements are being presented to reflect the current corporate governance structure.

 

25.1

Operating segments

 

     06/2020  
     Reconciliation to net profit (loss) for the period  
     Net Income      Performance
assessed by the
Company
    Depreciation
and
Amortization
    Financial
income
     Financial
Expenses
    Income tax     Net Profit
(Loss)
 

Natura &Co Latam

     8,138,082        680,802       (458,872     1,749,654        (1,932,291     (207,473     (168,179

Avon International

     3,771,535        40,361       (390,836     356,290        (676,915     (12,223     (683,323

TBS International

     1,872,436        278,581       (356,197     43,491        (75,346     (57,290     (166,761

Aesop International

     723,121        180,574       (123,813     10,403        (28,729     (10,018     28,416  

Corporate expenses

     —          (431,830     —         65,884        (8,577     147,348       (227,175
  

 

 

    

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Consolidated

     14,505,174        748,488       (1,329,718     2,225,772        (2,721,858     (139,656     (1,217,022
  

 

 

    

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

 

     06/2019  
     Reconciliation to net profit (loss) for the period  
     Net Income      Performance
assessed by the
Company
    Depreciation
and
Amortization
    Financial
income
     Financial
Expenses
    Income tax     Net Profit
(Loss)
 

Natura &Co Latam

     4,048,390        728,909       (167,260     769,227        (1,102,304     (79,148     149,425  

TBS International

     1,717,823        286,527       (286,141     18,140        (46,057     12,983       (14,548

Aesop International

     552,646        118,183       (83,299     4,792        (13,455     (7,802     18,419  

Corporate expenses

     —          (127,120     —         —          —         43,221       (83,899
  

 

 

    

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Consolidated

     6,318,859        1,006,499       (536,700     792,159        (1,161,816     (30,746     69,397  
  

 

 

    

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

 

     06/2020      12/2019  
     Non-current
assets
     Total assets      Current
liabilities
     Non-current
liabilities
     Non-current
assets
     Total assets      Current
liabilities
     Non-current
liabilities
 

Natura &Co Latam

     9,204,837        17,876,818        5,937,239        10,281,619        4,574,087        9,328,858        3,116,454        8,235,679  

Avon International

     25,758,269        29,338,889        3,415,813        12,056,797        —          —          —          —    

TBS International

     7,726,417        9,828,551        1,989,604        1,885,255        6,146,960        7,369,250        1,065,447        1,477,148  

Aesop International

     1,338,875        1,954,858        418,223        730,817        1,033,408        1,435,830        255,616        590,917  

Corporate balance

     —          2,093,806        1,103,010        1,082        —          3,050,574        3,080,906        —    
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated

     44,028,398        61,092,922        12,863,889        24,955,570        11,754,455        21,184,512        7,518,423        10,303,744  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

F-40


LOGO

 

25.2

Net income and non-current assets by geographic region

 

     06/2020      06/2019  

Net income

   Natura &Co
Latam
     Avon
International
     TBS
International
     Aesop
International
     Natura &Co
Latam
     TBS
International
     Aesop
International
 

Asia

     —          653,102        101,024        356,245        —          137,196        225,245  

North America

     1,650,053        —          269,200        113,706        345,507        305,852        88,129  

Mexico

     1,328,100                 343,888        —          —    

Other

     321,953           269,200        113,706        1,619        305,852        88,129  

South America

     6,485,785        —          —          —          3,700,224        —          —    

Brazil

     4,533,315        —          —          —          2,776,153        —          —    

Argentina

     690,221                 355,098        —          —    

Others

     1,262,249        —          —          —          568,973        —          —    

Europe, Middle East and Africa (EMEA)

     2,244        3,118,433        1,351,971        154,393        2,659        1,157,888        100,838  

United Kingdom

     —          371,923        1,083,032        82,005        —          881,543        48,801  

Others

     2,244        2,746,510        268,939        72,388        2,659        276,345        52,037  

Oceania

     —          —          150,241        98,777        —          116,887        138,434  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated

     8,138,082        3,771,535        1,872,436        723,121        4,048,390        1,717,823        552,646  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

     06/2020      12/2019  

Non-current assets

   Natura &Co
Latam
     Avon
International
     TBS
International
     Aesop
International
     Natura &Co
Latam
     TBS
International
     Aesop
International
 

Asia

     —          245,854        170,999        298,185        —          140,760        227,670  

North America

     699,318        —          626,188        365,465        185,646        523,351        272,676  

Mexico

     602,043                 183,250        

Others

     97,275           626,188        365,465        2,396        523,351        272,676  

South America

     8,495,351        —          —          —          4,378,676        —          —    

Brazil

     6,985,784        —          —          —          4,197,259        —          —    

Argentina

     355,420                 63,050        

Others

     1,154,147        —          —          —          118,367        —          —    

EMEA

     10,168        25,512,415        6,452,367        234,424        9,765        5,105,903        190,442  

United Kingdom

     —          23,781,822        5,780,380        97,827        —          4,602,066        76,073  

Others

     10,168        1,730,593        671,987        136,597        9,765        503,837        114,369  

Oceania

     —          —          476,863        440,801        —          376,946        342,620  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated

     9,204,837        25,758,269        7,726,417        1,338,875        4,574,087        6,146,960        1,033,408  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

No individual or aggregate customer (economic group) represents more than 10% of the Company’s net income.

 

F-41


LOGO

 

25.3

Reconciliation for recast segments

Because of the new segment information as a result of the Avon acquisition in 2020, described above, the changes in the recast segment information previously disclosed is according to the following:

 

Presented in the financial statement for the year ended 31 December 2019

 

31 December 2019

   Non-current
assets
     Total assets      Current
liabilities
     Non-current
liabilities
 

Natura Brasil (a)

     4,181,261        7,618,551        2,207,944        8,119,890  

Natura LATAM (a)

     349,698        1,592,912        774,521        105,423  

Natura others (a)

     12,161        18,126        8,591        1,558  

Aesop (b)

     1,035,432        1,442,214        274,539        592,531  

The Body Shop (c)

     6,175,903        7,462,135        1,171,922        1,484,342  

Corporate

     —          3,050,574        3,080,906        —    
  

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated

     11,754,455        21,184,512        7,518,423        10,303,744  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(a)

Amounts included in the new segment information Natura &Co Latam.

(b)

Amounts related to the Aesop’s operations located in Brazil and Latins America, representing non-current asset (R$ 2.024), total assets (R$ 6.384), current liabilities (R$ 18.923) and non current liabilities (R$1.614) included in the recast segment Natura &Co Latam.

(c)

Amount related to The Body Shop’s operations located in Brazil and Latins America, representing non-current asset (R$ 28.943), total assets (R$92.885), current liabilities (R$106.475) and non current liabilities (R$7.193) included in the recast segment Natura &Co Latam.

 

Presented in the financial statement for the period ended 30 June 2019

 

30 June 2019

   Net
revenue
     Performance
assessed by the
Company
    Depreciation
and
amortization
    Financial
income
     Financial
expenses
    Income
tax
    Net
income
(loss)
 

Natura Brasil (a)

     2,750,169        588,399       (130,112     749,538        (1,071,733     (54,149     81,943  

Natura LATAM (a)

     1,253,535        162,932       (28,027     19,689        (27,504     (24,900     102,190  

Natura outros (a)

     4,292        (15,780     (1,093     —          (121     —         (16,994

Aesop (b)

     554,090        117,590       (83,761     4,792        (13,520     (7,802     17,299  

The Body Shop (c)

     1,756,773        280,479       (293,707     18,140        (48,938     12,884       (31,142

Corporate

     —          (127,120     —         —          —         43,221       (83,899
  

 

 

    

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Consolidated

     6,318,859        1,006,500       (536,700     792,159        (1,161,816     (30,746     69,397  
  

 

 

    

 

 

   

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

 

(a)

Amounts included in the new segment information Natura &Co Latam.

(b)

Amounts related to the Aesop’s operations located in Brazil and Latins America, representing net revenue (R$ 1.444), performance assessed by Company (R$ 593), depreciation and amortization (R$ 462), financial expense (R$65), and net income (loss) (R$1.120) included in the recast segment Natura &Co Latam.

(c)

Amount related to The Body Shop’s operations located in Brazil and Latins America, representing net revenue (R$ 38.950), performance assessed by Company (R$ 6.048), depreciation and amortization (R$ 7.566), financial expense (R$2.881), income tax (R$99) and net income (loss) (R$16.594) included in the recast segment Natura &Co Latam.

 

F-42


LOGO

 

26.

NET REVENUE

 

     Consolidated  
Gross income:    06/2020      06/2019  

Domestic market

     6,317,607        3,927,472  

Foreign market

     12,274,126        4,616,739  

Other sales

     242,336        26,306  
     18,834,069      8,570,517  

Returns and cancellations (a)

     (270,994      (31,947

Commercial discounts and rebates (a)

     (409,895      (507,871

Taxes on sales (a)

     (3,648,006      (1,711,841
  

 

 

    

 

 

 
     (4,328,895      (2,251,658
  

 

 

    

 

 

 

Net revenue

     14,505,174        6,318,859  
  

 

 

    

 

 

 

Substantially, the income from brands Natura and Avon refers to direct sales, whereas the income from the brands The Body Shop and Aesop refers to retail sales.

 

(a)

The comparative amounts for the period ended 30 June 2019, presented in the interim financial statement 30 June 2020, previously issued in 13 August 2020, were reclassified to ensure consistency with the information originally disclosed in the interim financial statement of 30 June 2019. The reclassifications were made between lines with no modification in the subtotals and totals.

 

27.

OPERATING EXPENSES AND COST OF PRODUCTS SOLD

 

Breakdown by function

   Controlling Company      Consolidated  
     06/2020      06/2019      06/2020      06/2019  

Cost of products sold

        —          5,254,229        1,773,727  

Expenses with sales, marketing and logistics

        —          6,448,997        2,875,375  

Administrative, R&D, IT and Project Expenses

     23,970        —          2,603,635        1,104,252  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

     23,970        —          14,306,861        5,753,354  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

Breakdown by nature

   Controlling Company      Consolidated  
     06/2020      06/2019      06/2020      06/2019  

Cost of products sold

        —          5,254,229        1,773,727  
     

 

 

    

 

 

    

 

 

 

Raw material/packaging material/resale

        —          4,365,991        1,485,379  

Personnel expenses (explanatory note 28)

        —          285,508        145,572  

Depreciation and amortization

        —          98,639        28,028  

Others

        —          504,091        114,748  
     

 

 

    

 

 

    

 

 

 

Expenses with sales, marketing and logistics

        —          6,448,997        2,875,375  
     

 

 

    

 

 

    

 

 

 

Logistics costs

        —          1,063,015        344,782  

Personnel expenses (explanatory note 28)

        —          1,839,299        805,518  

Marketing, sales force and other sale expenses

        —          2,884,442        1,367,657  

Depreciation and amortization

        —          662,241        357,418  
  

 

 

    

 

 

    

 

 

    

 

 

 

Administrative, R&D, IT and Project Expenses

     23,970        —          2,603,635        1,104,252  
  

 

 

    

 

 

    

 

 

    

 

 

 

Expenses in innovation

        —          115,977        33,277  

Personnel expenses (explanatory note 28)

     20,908        —          1,031,894        585,142  

Other administrative expenses

     3,062        —          886,926        334,579  

Depreciation and amortization

        —          568,838        151,254  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

     23,970        —          14,306,861        5,753,354  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

28.

EMPLOYEE BENEFITS

Information pertaining to employee benefits was presented in the Company’s 2019 annual financial statements in Note 27.

 

     Controlling Company      Consolidated  
     06/2020      06/2019      06/2020      06/2019  

Payroll, profit sharing and bonuses

     11,629        —          2,312,050        1,146,868  

Supplementary Pension Plan

     —          —          89,581        43,605  

Share-based payments (note 32.3)

     4,131        —          76,387        26,903  

Charges on restricted stock (note 32.1)

     2,381        —          11,475        15,670  

Medical care, food, and other benefits

     —          —          291,956        120,311  

Charges, taxes and social contributions

     74        —          284,248        98,699  

INSS - Brazilian Social Security Institute

     2,693        —          91,004        84,176  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

     20,908        —          3,156,701        1,536,232  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

F-43


LOGO

 

28.1

Share-based payments

Options granted in 2020

On 27 March 2020, the Company’s Board of Directors approved the new long-term stock-based incentive plans of the Company named the “Co-investment Plan” and “Long-term Incentive Plan” for 2020.

The “Co-Investment Plan” consists of the grant of common shares of the Company to a group of employees that may invest part of their profit participation (up to 50%) in the purchase of shares so that the Company will assign the same number of shares for the amount invested by the beneficiary. The rights of the participants regarding the “Co-Investment Plan” shall only be fully acquired, to the extent that the participant remains continuously linked as an employee of the Company and its subsidiaries up to the third anniversary of the date of the grant.

The “Long-Term Incentive Plan” consists of granting common shares of the Company to a group of employees and, unless otherwise determined by the Company’s Board of Directors, participants’ rights regarding the Performance Shares shall only be fully acquired, to the extent that: (i) the participant remains an employee of the Company and its subsidiaries until the 3rd anniversary of the grant date; and (ii) certain performance conditions are met. For certain participants, there is a special condition for item (i) above, in which 50% of the Performance Shares granted will be acquired on the 3rd anniversary of the grant date and the remaining 50% on the 4th anniversary of the grant date.

The variations in the number of outstanding stock options and their related weighted-average prices, as well as variations in the number of restricted stock, are as follows:

 

Stock Option Plan and Strategy Acceleration Plan

 
     Average exercise price
per option - R$
     Options (thousands)  

Balance on 31 December 2019

     16.51        17,568  

Related to Avon subsidiary – Business Combination (Note 4)

     0.01        1,994  

Expired

     21.35        (72

Exercised

     26.35        (727
  

 

 

    

 

 

 

Balance on 30 June 2020

     16.29        18,763  
  

 

 

    

 

 

 

 

     Restricted stock
(thousands)
     Performance shares
(thousands)
 

Balance on 31 December 2019

     3,092        688  

Granted

     862        —    

Cancelled

     (22      —    

Exercised

     (1,046      (40
  

 

 

    

 

 

 

Balance on 30 June 2020

     2,886        648  
  

 

 

    

 

 

 

Out of the 18,763 thousand options existing as of 30 June 2020 (17,568 thousand options as of 31 December 2019) 2,312 thousand options (604 thousand options as of 31 December 2019) can be exercised.

The expense related to the fair value of the options and restricted stock, including the charges related to restricted shares, recognized in the six-month period ended 30 June 2020, according to the period elapsed for the acquisition of the right to exercise of options and restricted shares, was R$ 81,350 in the consolidated.

The options to purchase outstanding stock and restricted stock at the end of the period have the following maturity dates and exercise prices:

 

F-44


LOGO

 

As of 30 June 2020 - Stock option plan

 

Grant date

  

Conditions for acquisition

of a right as from the grant

date

   Exercise
price

(R$)
    

Fair value

(R$)

   Existing
options

(thousands)¹
     Remaining
contractual
life (years)
     Exercisable
options

(thousands)
 

18 March 2013

   4 years of service      37.60      6.05      386        0.2        386  

17 March 2014

   4 years of service      25.16      4.27      102        1.7        102  

16 March 2015

   2 to 4 years of service      13.60      4.85 to 5.29      210        2.7        210  

28 July 2015 (Strategy acceleration)

   4 to 5 years of service      12.90      6.20 to 6.23      1,296        3.1        196  

15 March 2016

   2 to 4 years of service      12.84      7.16 to 7.43      286        3.8        284  

11 July 2016 (Strategy acceleration)

   4 to 5 years of service      11.41      6.84 to 6.89      2,640        4.1        —    

10 March 2017

   2 to 4 years of service      12.59      6.65 to 6.68      696        4.8        372  

10 March 2017 (Strategy acceleration)

   4 to 5 years of service      12.59      6.87 to 6.89      2,210        4.8        —    

12 March 2018

   2 to 4 years of service      16.96      7.96 to 8.21      1,998        5.8        642  

12 March 2018 (Strategy acceleration)

   3 to 5 years of service     

12.16
to
16.96
 
 
 
   8.21 to 9.67      3,800        5.8        —    

12 April 2019

   3 to 4 years of service      23.54      11.71 to 11.82      1,636        6.8        —    

12 April 2019 (Strategy acceleration)

   4 to 5 years of service      23.54      11.51 to 11.71      1,900        6.8        —    

From 31 December 2020 to 9 May 2017

   1 year of service      0.01      19.80      65        —          65  

From 14 March 2018 to 17 December 2018

   1 to 3 years of service      0.01      19.70      334        1.2        55  

From 13 March 2019 to 16 December 2019

   1 to 3 years of service      0.01      19.58      1,204       

0.4
a
2.2
 
 
 
     —    
           

 

 

       

 

 

 
              18,763           2,312  
           

 

 

       

 

 

 

As of 30 June 2020 - Restricted stock

 

Grant date

   Conditions for acquisition
of a right as from the grant date
     Existing shares
(thousands)2
     Fair value
(R$)
     Remaining
contractual life
(years)
 

10 March 2017

     2 to 4 years of service        206        11.69 to 12.51        0.7  

12 March 2018 – Plan I

     2 to 4 years of service        470        15.18 to 15.9        0.7  

12 March 2018 – Plan II

     0.4 to 2.4 years of service        90        15.76 to 16.49        0.1  

12 March 2018 – Plan III

     1 to 3 years of service        74        15.54 to 16.27        0.8  

12 March 2018 – Extraordinary Plan I

     1 to 3 years of service        4        15.54 to 16.28        0.7  

13 August 2018 – Extraordinary Plan VI

     1.6 to 3.6 years of service        50        12.24 to 13.13        0.7 to 1.7  

12 April 2019 – Plan I

     2 to 4 years of service        814        21.62 to 22.53        0.7 to 2.8  

12 April 2019 – Plan II

     1 to 3 years of service        312        22.14 to 22.85        0.7 to 1.7  

27 March 2020 – Co-Investment Plan

     1 to 3 years of service        866        29.00        3  
     

 

 

       
        2,886        
     

 

 

       

As of 30 June 2020 – Performance shares

 

Grant date

  

Right acquisition conditions

  

Existing shares

(thousands)

  

Fair value

(R$)

  

Remaining
contractual life
(years)

  

Shares not
delivered

(thousands)

21 May 2019

   From 3 to 4 years of service as from the grant date and if the performance conditions are met    648    23.10 to 45.70    3.0 to 4.0    —  
     

 

        

 

      648          —  
     

 

        

 

 

F-45


LOGO

 

As of 30 June 2020, the market price was R$ 39.90 (R$ 38.67 as of 31 December 2019) per share.

 

29.

FINANCIAL INCOME (EXPENSES)

 

     Controlling Company      Consolidated  
     06/2020      06/2019      06/2020      06/2019  

FINANCIAL INCOME:

           

Interest on financial applications

     13,450        —          74,306        37,445  

Earnings on monetary and exchange rate variations (a)

     —          —          394,807        410,393  

Earnings on swap and forward transactions (c)

     —          —          1,634,968        318,873  

Earnings on market value adjustment of swap and forward derivatives

     —          —          3,020        1,003  

Reversal of the monetary adjustment of the provision for tax risks and tax obligations

     —          —          42,378        —    

Debt structuring revenues for acquisition of Avon

     52,434        —          52,434        —    

Other financial income

     —          —          23,809        24,445  
  

 

 

    

 

 

    

 

 

    

 

 

 
     65,884        —          2,225,722        792,159  
  

 

 

    

 

 

    

 

 

    

 

 

 

FINANCIAL EXPENSES:

           

Interest on financing

     (4,757      —          (539,671      (257,764

Interest on lease

     —          —          (119,398      (64,137

Losses on monetary and exchange rate variations (b)

     —          —          (1,529,458      (311,015

Losses on swap and forward transactions (d)

     —          —          (431,567      (455,352

Losses on market value adjustment of swap and forward derivatives

     —          —          (5,170      (786

Adjustment of provision for tax, civil and labor risks and tax liabilities

     —          —          (6,410      (8,080

Appropriation of funding costs (Debentures/Notes)

     —          —          (5,653      (6,452

Pension plan interest

     —          —          (15,512      —    

Adjustment for hyperinflationary economy (Argentina)

     —          —          (5,556      (5,864

Debt structuring expenses for acquisition of Avon

              (29,360
  

 

 

    

 

 

    

 

 

    

 

 

 

Other financial expenses

     (3,821      —          (63,463      (23,006
  

 

 

    

 

 

    

 

 

    

 

 

 
     (8,578      —          (2,721,858      (1,161,816
  

 

 

    

 

 

    

 

 

    

 

 

 

Net financial income (expenses)

     57,306        —          (496,136      (369,657
  

 

 

    

 

 

    

 

 

    

 

 

 

The objective of the breakdowns below is to explain more clearly the foreign exchange hedging transactions contracted by the Company and the related balancing items in the income statement shown in the previous table:

 

     Controlling
Company
     Consolidated  
     06/2020      06/2019      06/2020      06/2019  

(a) Earnings on monetary and exchange rate variations

     —          —          394,807        410,393  
  

 

 

    

 

 

    

 

 

    

 

 

 

Earnings on exchange rate variation on borrowings

     —          —          (393      313,365  

Exchange rate variation on imports

     —          —          15,746        6,541  

Exchange rate variation on export receivables

     —          —          46,580        7,322  

Exchange rate variation on accounts payable to subsidiaries abroad

     —          —          183,468        83,165  

Exchange variations of bank accounts in foreign currency

     —          —          149,406        —    

(b) Losses on monetary and exchange rate variations

     —          —          (1,529,458      (311,015
     

 

 

    

 

 

    

 

 

 

Losses on exchange rate variation on borrowings

        —          (1,089,680      (228,287

Exchange rate variation on imports

        —          (43,774      (9,791

Exchange rate variation on export receivables

        —          (7,901      (8,483

Exchange rate variation on accounts payable to subsidiaries abroad

        —          (192,414      (64,220

Monetary variations on financing

        —          (195,689      (234

(c) Earnings on swap and forward transactions

        —          1,634,968        318,873  
     

 

 

    

 

 

    

 

 

 

Income from swap exchange coupons

        —          112,090        86,811  

Earnings from exchange variations on swap instruments

        —          1,522,878        232,062  

(d) Losses on swap and forward transactions

        —          (431.567      (455,352
     

 

 

    

 

 

    

 

 

 

Losses on exchange rate variation on swap instruments

        —          (5,892      (314,136

Financial costs of swap instruments

        —          (425,585      (141,216

 

F-46


LOGO

 

30.

OTHER OPERATING INCOME (EXPENSES), NET

Information pertaining to other operating income (expenses) was presented in the Company’s 2019 annual financial statements in Note 29.

 

     Controlling Company      Consolidated  
     06/2020      06/2019      06/2020      06/2019  

Other operating income, net

           

Result of write-off of property, plant and equipment

     —          —          8,620        142  

ICMS-ST

     —          —          14,345        39,722  

Income from the sale of clients’ portfolio

     —          —          —          10,125  

Tax credits

     —          —          101,473        96,062  

Other operating income

     —          —          7,764        —    
  

 

 

    

 

 

    

 

 

    

 

 

 

Total other operating income

     —          —          132,202        146,051  
  

 

 

    

 

 

    

 

 

    

 

 

 

Other operating expenses, net

           

Crer para Ver

     —          —          (19,720      (16,771

Expenses from the sale of clients’ portfolio

     —          —          (2,967      —    

Expenses related to the acquisition of Avon(a)

     (166,416      —          (304,057      (67,497

Transformation Plan

     —          —          (79,558      (26,374

Tax contingencies

     —          —          (3,774      (3,926

Other operating expenses

     (11,432      —          —          (9,151
  

 

 

    

 

 

    

 

 

    

 

 

 

Total other operating expenses

     (177,848      —          (410,076      (123,719
  

 

 

    

 

 

    

 

 

    

 

 

 

Other operating income (expenses), net

     (177,848      —          (277,874      22,332  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(a)

Related to expenses associated with the Avon acquisition process, which include: financial structuring expenses (R$ 115,696), legal expenses (R$ 17,281), regulatory expenses (R$ 18,030) and executive plans (R$ 152,909).

 

31.

TRANSACTIONS WITH RELATED PARTIES

Information pertaining to transactions with related parties was presented in the Company’s 2019 annual financial statements in Note 31.

 

31.1

The balances receivable and payable per transaction with related parties are set out below:

 

     Controlling Company  
     06/2020      12/2019  

Current Assets:

     

Avon Products, Inc. (a)

     501,074        —    

Natura Cosméticos S.A. – Argentina (b)

     1,798        —    

Natura Cosméticos S.A. – Mexico (b)

     527        —    

Natura Cosméticos S.A. – Peru (b)

     454        —    

Natura Cosméticos Ltda. – Colombia (b)

     338        —    

Natura Cosméticos Ltda – Chile (b)

     290        —    

The Body Shop International

     2,395     
  

 

 

    

 

 

 

Total Current Assets (*)

     506,876        —    
  

 

 

    

 

 

 

Current Liabilities:

     

Natura Cosméticos S.A. – Brazil (a)

     330        —    
  

 

 

    

 

 

 

Total current liabilities

     330        —    
  

 

 

    

 

 

 

 

(a)

Pertains to the allocation of expenses related to the merger process.

(b)

Pertains to the allocation of expenses related to the stock option and restricted stock plans.

In the period ended 30 June 2020, Natura &Co reimbursed the amount of R$ 147,486 related to the transaction costs of the Avon acquisition paid by its controlled company Natura Cosméticos. This reimbursement impacted the result under “Other income (expenses)”.

The Natura Institute holds shares in the Essential Investment Fund, and on 30 June 2020 its balance was R$ 3,395 (R$ 3,766 as of 31 December 2019).

On 5 June 2012, an agreement was entered between Indústria e Comércio de Cosméticos Natura Ltda. and Bres Itupeva Empreendimentos Imobiliários Ltda. (“Bres Itupeva”), for the construction and lease of processing, storage and distribution of merchandise (HUB) in the city of Itupeva/SP. In 2019, Bres Itupeva granted its credits to BRC Securitizadora S/A, to which Natura makes monthly payments. Mr. Antônio Luiz da Cunha Seabra, Mr. Guilherme Peirão Leal and Mr. Pedro Luiz Barreiros Passos, members of the group of controlling shareholders of Natura Cosméticos S.A., indirectly hold a controlling interest in Bres Itupeva. The amount involved in the registered transaction is recorded under “Right of Use” of Buildings in the amount of R$ 41,809 (R$ 44,244 under “Buildings” of Property, Plant and Equipment as of 31 December 2019).

In the period ended 30 June 2020, the Company and its subsidiaries transferred to the Natura Institute, in the form of a donation associated with maintenance, the amount of R$ 692 corresponding to 0.5% of net income for the prior fiscal year, and a donation associated with the net sales of products of the Natura Crer Para Ver line in the amount of R$ 21,000 (R$ 12,500 as of 30 June 2019).

 

F-47


LOGO

 

31.2

Compensation of the Management’s key personnel

The total compensation of the key personnel of the Company’s Management is as follows:

 

     06/2020      06/2019  
     Compensation      Compensation  
     Fixed      Variable      Total      Fixed      Variable      Total  
     (a)      (b)      (a)      (b)  

Board of Directors

     7,591        20,619        28,210        10,230        15,782        26,012  

Executive Office

     22,661        39,574        62,235        19,963        30,153        50,116  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     30,252        60,193        90,445        30,193        45,935        76,128  

 

a)

The item “Executive Office” includes the amount of R$ 510 pertaining to the amortization of the six-month period ended 30 June 2020 (R$ 29 in the six-month period ended 30 June 2019), of the Confidentiality and Non-Compete Agreement (“Agreement”).

b)

This refers to profit sharing, the Restricted Stock Plan and Strategy Acceleration Program, including charges, as applicable, to be determined in the period. The amounts include additions to and/or reversals of provisions made in the previous year, due to final assessment of the targets established for statutory and non-statutory board members and officers in relation to profit sharing.

 

31.2.1

Share-based payments

Breakdown of the compensation of the Company’s executives:

 

     Grant of options  
     06/2020      06/2019  
     Balance of
the

Options
(quantity)1

(a)
     Average fair
value of the
options1 -R$
     Average
exercise
price1

- R$ (b)
     Balance of
the

Options
(quantity)1 (a)
     Average fair
value of the
options1 -R$
     Average
exercise
price1 -
R$ (b) 
 

Executive Office

     13,723,236        8.39        16.29        14,203,364        8.24        16.43  

 

     Restricted stock  
     06/2020      06/2019  
     Balance of the
shares (quantity)2 (a)
     Average fair value2
- R$
     Balance of the
shares (quantity)2 (a)
     Average fair value2
- R$
 

Executive Office

     1,564,143        25.15        1,069,642        19.05  

 

1 

The number of stock options granted, expired and exercised and their respective fair values is shown already considering the stock split approved at the Extraordinary Shareholders’ Meeting held on 17 September 2019.

2 

The number of restricted stock and performance shares granted, expired and exercised is shown already considering the stock split approved at the Extraordinary Shareholders’ Meeting held on 17 September 2019.

 

(a)

This refers to the balance of the vested options and restricted stock and non-vested options and restricted stock, not exercised, at the balance sheet dates.

(b)

This refers to the weighted average exercise price of the option at the time of the grant plans, adjusted for inflation based on the Extended Consumer Price Index (IPCA) until the balance sheet dates. The new Stock Option Program implemented in 2015 includes no monetary adjustment.

 

32.

COMMITMENTS

 

32.1

Contracts related to supply of inputs

Subsidiary Indústria e Comércio de Cosméticos Natura Ltda. has commitments arising from electric power supply agreements, with effective physical delivery, for its manufacturing activities, as described below:

 

   

Agreements that started in 2018 and are effective up to 2020, with the value of Megawatts/h between R$ 265 and R$ 363.

 

   

Agreements that started in 2019 and are effective up to 2022, with the value of Megawatts/h between R$ 155 and R$ 305.

 

F-48


LOGO

 

   

Agreements that started in 2020 and are effective up to 2022, with the value of Megawatts/h between R$ 204 and R$ 238.

The amounts are shown based on electric power consumption estimates in accordance with the contractual period, the prices of which are based on volumes, also estimated, resulting from the subsidiary’s continuous operations.

The total minimum supply payments, measured at nominal value, according to the contract, are:

 

     06/2020      12/2019  

Up to one year

     10,206        17,918  

One to five years

     2,552,017        13,160  
  

 

 

    

 

 

 

Total

     2,562,223        31,078  
  

 

 

    

 

 

 

 

33.

INSURANCE COVERAGE

The Company and its subsidiaries adopt an insurance policy that mainly considers risk concentration and its relevance, taking into consideration the nature of their activities and the opinion of their insurance advisors. As of 30 June 2020, insurance coverage is as follows:

 

Item

  

Type of coverage

   Amount insured  
   06/2020      12/2019  
Industrial complex and administrative sites    Any material damage to buildings, facilities, inventories, and machinery and equipment      5,511,760        2,322,801  
Vehicles    Fire, theft and collision for 347 vehicles (818 in 2019)      259,004        212,027  
Loss of profits    Loss of profits due to material damage to facilities, buildings and production machinery and equipment      1,582,000        1,582,000  
Transport    Damage to products in transit.      97,086        32,309  
Civil liability    Protection against errors or complaints in the exercise of professional activity that affect third parties      1,392,756        532,510  
Environmental liability    Protection against environmental accidents that may result in environmental lawsuits      30,000        30,000  

 

34.

ADDITIONAL INFORMATION TO THE CASH FLOW STATEMENTS

The following table presents additional information on transactions related to the cash flow statement:

 

     Controlling Company      Consolidated  
     06/2020      06/2019      06/2020      06/2019  

Non-cash items:

           

Hedge accounting, net of tax effects

        —          153,114        105,997  

Net effect of the additions to the property, plant and equipment/intangible assets still not paid

        —          46,778        31,638  

Consideration per acquisition of the subsidiary*

     13,366        —             —    

 

*

in millions of Reais

 

35.

SUBSEQUENT EVENTS

Entity acquisition

At 30 June 2020 The Body Shop International Limited signed a purchase and sale agreement to acquire Aeon Forest Co., Ltd for the amount of R$133.275 (¥2,623,000). Until the date of this financial statement issuance, The Body Shop have not acquired control over the purchased entity, which will occur after the issuance of this financial statement.

Resource remittance to subsidiary

On 2 July 2020, the Company remitted to its subsidiary Natura &Co International S.à r.l. the amount of R$ 252,334 (USD47,000), aligned with the purpose of the subsidiary, which is raise and borrow funds by the Company to other consolidated companies (Note 2.3).

 

F-49


LOGO

 

36.

APPROVAL FOR ISSUE OF THE INTERIM ACCOUNTING INFORMATION

The Company’s interim accounting information was approved for disclosure by the Board of Directors at the meeting held on 30 September 2020.

 

F-50

Natura (NYSE:NTCO)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Natura Charts.
Natura (NYSE:NTCO)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Natura Charts.